SI5 Global
✓ Produto localizado
Medicamentos E Saúde

VIAGRA 50MG CAIXA 8 COMP REV

Viagra
GTIN / EAN
7908236800162
CEST
Não informado
Conteúdo
Não informado

Dados de produto preservados no idioma original.

VIAGRA 50MG CAIXA 8 COMP REV é fabricado pela Viagra, na categoria Medicamentos E Saúde, com código de barras 7908236800162. Classificado no NCM 30039033 (Ácido glucônico, seus sais ou seus ésteres).

Fonte: SI5 Global · código registrado em Brasil · atualizado em 02/10/2026

WhatsApp

Preço base (referência): R$ 250,99 — coletado em extrafarma.com.br em 02/10/2026, pode não estar atualizado

Código de barras

7908236800162

Código de barras 7908236800162

Código registrado em Brasil · prefixo 790

Classificação fiscal

NCM
30039033Ácido glucônico, seus sais ou seus ésteres

Descrição do produto

O que é Viagra 50mg 8 Comprimidos Revestidos?

O Viagra 50mg 8 Comprimidos Revestidos é um medicamento de referência, cujo princípio ativo é o citrato de sildenafila. Ele é indicado para o tratamento da disfunção erétil, condição que afeta a capacidade de obter ou manter uma ereção peniana firme o suficiente para um desempenho sexual satisfatório. O Viagra age dilatando os vasos sanguíneos no pênis, o que aumenta o fluxo de sangue para a região e facilita a ereção quando há estímulo sexual. É importante ressaltar que o medicamento não provoca a ereção por si só, sendo necessária a estimulação para que seu efeito seja observado. Sua ação começa aproximadamente 1 hora após a ingestão.

Conteúdo da embalagem: 8 comprimidos revestidos.

Fabricado por: Viatris

Indicação etária: Uso adulto.

Composição Viagra 50mg 8 Comprimidos Revestidos:

Princípio ativo: citrato de sildenafila 50mg

Excipientes: celulose microcristalina, fosfato de cálcio dibásico (anidro), croscarmelose sódica, estearato de magnésio, Opadry Azul (hipromelose, lactose, triacetina, índigo carmim alumínio laca e dióxido de titânio) e Opadry Transparente (hipromelose e triacetina).

Para que serve Viagra?

O Viagra (citrato de sildenafila) é um medicamento desenvolvido especificamente para homens adultos que enfrentam dificuldades com a função erétil. Sua principal finalidade é restaurar a capacidade de resposta à estimulação sexual, permitindo uma vida sexual mais satisfatória.

  • Tratamento da disfunção erétil, também conhecida como impotência sexual.
  • Ajuda a obter uma ereção rígida o suficiente para a penetração.
  • Auxilia a manter a ereção durante a atividade sexual.

Como devo tomar Viagra 50mg?

Para garantir a eficácia e segurança do tratamento com Viagra, siga as orientações de uso ou a prescrição médica. O medicamento deve ser administrado da seguinte forma:

  • Uso oral: O comprimido deve ser engolido inteiro, com um pouco de líquido.
  • Dosagem: A dose recomendada é de 50mg, tomada aproximadamente 1 hora antes da relação sexual.
  • Ajuste de dose: Conforme a eficácia e tolerabilidade, a dose pode ser aumentada para 100mg ou diminuída para 25mg, sempre com orientação médica.
  • Frequência: Não exceder a dose máxima de 1 vez ao dia.
  • Importante: O comprimido de Viagra não deve ser partido, aberto ou mastigado.
  • Lembre-se que o estímulo sexual é necessário para que o medicamento funcione adequadamente.

Quando não devo tomar Viagra?

O uso de Viagra é contraindicado em algumas situações específicas. Não utilize este medicamento se você:

  • Estiver em tratamento com medicamentos que contenham nitratos (usados para tratar angina ou dor no peito), doadores de óxido nítrico ou nitritos orgânicos.
  • Utiliza estimuladores da guanilato ciclase, como o riociguate.
  • Tiver hipersensibilidade (alergia) conhecida ao citrato de sildenafila ou a qualquer outro componente da fórmula.
  • For mulher ou menor de 18 anos.
  • Possuir condições médicas que desaconselhem a atividade sexual, como problemas cardiovasculares graves.
  • Tiver histórico de neuropatia óptica isquêmica não-arterítica ou retinite pigmentosa hereditária.

Ficha técnica

Medicamento
True
MarcaPropria
Não
NumeroRegistroMS
1.0216.0262.003-1
DescricaoBula
%0A%09%09%09%09%09%09%3Cp%3E%3Cstrong%3EAPRESENTA%26%23xC7%3B%26%23xD5%3BES%26%23xA0%3B%26%23xA0%3B%26%23xA0%3B%3C%2Fstrong%3E%3Cstrong%3E%26%23xA0%3B%26%23xA0%3B%20%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3EComprimido%20revestido%2050mg%3C%2Fp%3E%0A%3Cp%3EEmbalagens%20contendo%201%2C%202%2C%204%2C%208%20e%2012%20comprimidos.%3C%2Fp%3E%0A%3Cp%3E%26%23xA0%3B%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3E%3Cstrong%3EUSO%20ORAL%26%23xA0%3B%26%23xA0%3B%26%23xA0%3B%26%23xA0%3B%26%23xA0%3B%20%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EUSO%20ADULTO%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3E%26%23xA0%3B%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3ECOMPOSI%26%23xC7%3B%26%23xC3%3BO%26%23xA0%3B%26%23xA0%3B%26%23xA0%3B%26%23xA0%3B%26%23xA0%3B%26%23xA0%3B%26%23xA0%3B%26%23xA0%3B%26%23xA0%3B%26%23xA0%3B%20%3C%2Fstrong%3E%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3ECada%20comprimido%20revestido%20de%2050mg%20cont%26%23xE9%3Bm%3A%3C%2Fp%3E%0A%3Cp%3Ecitrato%20de%20sildenafila%20(equivalente%20a%2050mg%20de%20sildenafila)%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B70%2C225mg%3C%2Fp%3E%0A%3Cp%3EExcipiente%20q.s.p%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B.1%20comprimido%3C%2Fp%3E%0A%3Cp%3EExcipientes%3A%20celulose%20microcristalina%2C%20fosfato%20de%20c%26%23xE1%3Blcio%20dib%26%23xE1%3Bsico%20(anidro)%2C%20croscarmelose%20s%26%23xF3%3Bdica%2C%20estearato%20de%20magn%26%23xE9%3Bsio%2C%20Opadry%26%23xAE%3B%26%23xA0%3BAzul%20(hipromelose%2C%20lactose%2C%20triacetina%2C%20%26%23xED%3Bndigo%20carmim%20alum%26%23xED%3Bnio%20laca%20e%20di%26%23xF3%3Bxido%20de%20tit%26%23xE2%3Bnio)%2C%20Opadry%26%23xA0%3B%26%23xAE%3B%26%23xA0%3BTransparente%20(hipromelose%20e%20triacetina)%20e%20%26%23xE1%3Bgua%20purificada.%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3E%3Cstrong%3E%20INDICA%26%23xC7%3B%26%23xD5%3BES%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3EO%20citrato%20de%20sildenafila%20est%26%23xE1%3B%20indicado%20para%20o%20tratamento%20da%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%2C%20que%20se%20entende%20como%20sendo%20a%20incapacidade%20de%20atingir%20ou%20manter%20uma%20ere%26%23xE7%3B%26%23xE3%3B%20o%20suficiente%20para%20um%20desempenho%20sexual%20satisfat%26%23xF3%3Brio.%20Para%20que%20este%20medicamento%20seja%20eficaz%20%2C%20%26%23xE9%3B%20necess%26%23xE1%3Brio%20est%26%23xED%3Bmulo%20sexual.%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3E%20RESULTADOS%20DE%20EFIC%26%23xC1%3BCIA%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3EEm%20estudos%20cl%26%23xED%3Bnicos%2C%20o%20citrato%20de%20sildenafila%20foi%20avaliado%20em%20rela%26%23xE7%3B%26%23xE3%3Bo%20a%20seu%20efeito%2C%20em%20homens%20com%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20(DE)%2C%20na%20capacidade%20para%20realizar%20atividade%20sexual%20e%20em%20muitos%20casos%2C%20especificamente%2C%20ao%20efeito%20na%20capacidade%20de%20obter%20e%20manter%20uma%20ere%26%23xE7%3B%26%23xE3%3Bo%20suficiente%20para%20uma%20atividade%20sexual%20satisfat%26%23xF3%3Bria.%20O%20citrato%20de%20sildena%20fila%20foi%20avaliado%20primariamente%20em%20doses%20de%2025mg%2C%2050mg%20e%20100mg%20em%20ensaios%20cl%26%23xED%3Bnicos%20randomizados%2C%26%23xA0%3Bduplo-cegos%2C%26%23xA0%3Bplacebo-controlados%26%23xA0%3Bpor%20at%26%23xE9%3B%206%20meses%20de%20dura%26%23xE7%3B%26%23xE3%3Bo%2C%20usando%20v%26%23xE1%3Brios%20desenhos%20de%20estudo%20(dose%20fixa%2C%20titula%26%23xE7%3B%26%23xE3%3Bo%2C%20paralelo%2C%20cruzado).%20O%20citrato%20de%20sildenafila%20foi%20administrado%20para%20mais%20de%203000%20pacientes%20com%20idade%20de%2019%20a%2087%20anos%2C%20com%20DE%20de%20v%26%23xE1%3Brias%20etiologias%20(org%26%23xE2%3Bnica%2C%20psicog%26%23xEA%3Bnica%2C%20mista)%20com%20uma%20dura%26%23xE7%3B%26%23xE3%3Bo%20m%26%23xE9%3Bdia%20de%205%20anos.%20O%20citrato%20de%20sildenafila%20demonstrou%20melhora%20estatisticamente%20significativa%20comparada%20com%20placebo%20em%20todos%20os%20estudos.%20Os%20estudos%20que%20estabeleceram%20benef%26%23xED%3Bcio%20demonstraram%20melhoras%20na%20taxa%20de%20sucesso%20para%20rela%26%23xE7%3B%26%23xF5%3Bes%20sexuais%20comparado%20com%20placebo.%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3EA%20efic%26%23xE1%3Bcia%20de%20sildenafila%2C%20determinada%20como%20sendo%20acapacidade%20de%20alcan%26%23xE7%3Bar%20e%20manter%20uma%20ere%26%23xE7%3B%26%23xE3%3Bo%20suficiente%20para%20a%20rela%26%23xE7%3B%26%23xE3%3Bo%20sexual%2C%20foi%20demonstrada%20n%20os%20estudos%20e%20foi%20mantida%20nas%20extens%26%23xF5%3Bes%20de%20estudos%20(um%20ano).%20Nos%20estudos%20de%20dose%20fixa%2C%20a%20propor%26%23xE7%3B%26%23xE3%3Bo%20de%20pacientes%20que%20relataram%20que%20o%3C%2Fp%3E%0A%3Cp%3Etratamento%20melhorou%20a%20ere%26%23xE7%3B%26%23xE3%3Bo%20foi%20de%2062%25%20(25%20mg)%2C%2074%20%25%20(50%20mg)%20e%2082%25%20(100%20mg)%2C%20em%20compara%26%23xE7%3B%26%23xE3%3Bo%20a%2025%25%20para%20o%20placebo.%20Em%20adi%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE0%3B%20melhor%20a%20da%20DE%20(disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil)%2C%20a%20an%26%23xE1%3Blise%20do%20IIFE%20demonstrou%20que%20o%20tratamento%20com%20sildenafila%20tamb%26%23xE9%3Bm%20melhorou%20os%20aspectos%20relacionados%20ao%20orgasmo%2C%20a%20satisfa%26%23xE7%3B%26%23xE3%3Bo%20sexual%20e%20a%20satisfa%26%23xE7%3B%26%23xE3%3Bo%20no%20gera%20l.%3C%2Fp%3E%0A%3Cp%3EAo%20longo%20dos%20estudos%2C%20a%20propor%26%23xE7%3B%26%23xE3%3Bo%20de%20pacientes%20que%20relataram%20melhora%20com%20a%20utiliza%26%23xE7%3B%26%23xE3%3Bo%20de%20sildenafila%20foi%20de%2059%25%20dos%20pacientes%20diab%26%23xE9%3Bticos%2C%2043%25%20dos%20pacientes%20que%20sofreram%20prostatectomia%20total%20e%2083%25%20dos%20pacientes%20com%20les%26%23xF5%3Bes%20na%20medula%20espinhal%20(versus%2016%25%2C%2015%25%20e%2012%25%20com%20placebo%2C%20respectivamente).%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EDesfechos%20de%20Efic%26%23xE1%3Bcia%20em%20Ensaios%20Cl%26%23xED%3Bnicos%20Controlados%3C%2Fstrong%3E%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3EA%20efic%26%23xE1%3Bcia%20de%20citrato%20de%20sildenafila%20foi%20avaliada%20na%20maioria%20dos%20estudos%20usando%20v%26%23xE1%3Brios%20instrumentos%20de%20avalia%26%23xE7%3B%26%23xE3%3Bo.%20A%20medida%20prim%26%23xE1%3Bria%20nos%20principais%20estudos%20foi%20um%20question%26%23xE1%3Brio%20de%20fun%26%23xE7%3B%26%23xE3%3Bo%20sexual%20(o%20%26%23xCD%3Bndice%20Internacional%20de%20Fun%26%23xE7%3B%26%23xE3%3Bo%20Er%26%23xE9%3Btil%20%26%23x2013%3B%20IIEF)%20aplicado%20durante%20um%20per%26%23xED%3Bodo%20inicial%26%23xA0%3B(run-in)%26%23xA0%3Bsem%20tratamento%2C%20de%204%20semanas%2C%20no%20per%26%23xED%3Bodo%20basal%20(baseline)%2C%20em%20consultas%20de%20acompanhamento%20e%20no%20final%20do%20tratamento%20domiciliar%26%23xA0%3Bduplo-cego%2C%26%23xA0%3Bplacebo-controlado.%26%23xA0%3BDuas%20das%20quest%26%23xF5%3Bes%20do%20IIEF%20serviram%20de%20desfechos%20prim%26%23xE1%3Brios%20do%20estudo%3B%20respostas%20categorizadas%20foram%20obtidas%20para%20quest%26%23xF5%3Bes%20sobre%20(1)%20a%20capacidade%20de%20obter%20ere%26%23xE7%3B%26%23xF5%3Bes%20suficientes%20para%20ter%20rela%26%23xE7%3B%26%23xF5%3Bes%20sexuais%3C%2Fp%3E%0A%3Cp%3Ee%20(2)%20a%20manuten%26%23xE7%3B%26%23xE3%3Bo%20da%20ere%26%23xE7%3B%26%23xE3%3Bo%20ap%26%23xF3%3Bs%20a%20penetra%26%23xE7%3B%26%23xE3%3Bo.%20O%20paciente%20respondeu%20a%20ambas%20as%20quest%26%23xF5%3Bes%20na%20consulta%20final%20das%20%26%23xFA%3Bltimas%204%20semanas%20do%20estudo.%20As%20poss%26%23xED%3Bveis%20respostas%20categorizadas%20a%20estas%20quest%26%23xF5%3Bes%20foram%20(0)%20sem%20tentativa%20de%20rela%26%23xE7%3B%26%23xE3%3Bo%20sexual%2C%20(1)%20nunca%20ou%20quase%20nunca%2C%20(2)%20poucas%20vezes%2C%3C%2Fp%3E%0A%3Cp%3E(3)%26%23xE0%3Bs%20vezes%2C%20(4)%20na%20maioria%20das%20vezes%20e%20(5)%20quase%20sempre%20ou%20sempre.%20Foram%20tamb%26%23xE9%3Bm%20coletadas%20outras%20informa%26%23xE7%3B%26%23xF5%3Bes%20como%20parte%20do%20IIEF%20sobre%20outros%20aspectos%20da%20fun%26%23xE7%3B%26%23xE3%3Bo%20sexual%2C%20incluindo%20informa%26%23xE7%3B%26%23xF5%3Bes%20sobre%20a%20fun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%2C%20orgasmo%2C%20desejo%2C%20satisfa%26%23xE7%3B%26%23xE3%3Bo%20com%20a%20rela%26%23xE7%3B%26%23xE3%3Bo%20sexual%20e%20satisfa%26%23xE7%3B%26%23xE3%3Bo%20sexual%20geral.%20Os%20dados%20de%20fun%26%23xE7%3B%26%23xE3%3Bo%20sexual%20tamb%26%23xE9%3Bm%20foram%20registrados%20pelos%20pacientes%20em%20um%20di%26%23xE1%3Brio.%20Al%26%23xE9%3Bm%20disto%2C%20a%20efic%26%23xE1%3Bcia%20global%20foi%20questionada%20aos%20pacientes%20e%20opcionalmente%20foi%20administrado%20um%20question%26%23xE1%3Brio%20%26%23xE0%3B%20parceira.%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EResultados%20de%20efic%26%23xE1%3Bcias%20em%20estudos%20controlados%3C%2Fstrong%3E%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3EO%20efeito%20em%20um%20dos%20principais%20desfechos%2C%20manuten%26%23xE7%3B%26%23xE3%3Bo%20de%20ere%26%23xE7%3B%26%23xF5%3Bes%20ap%26%23xF3%3Bs%20a%20penetra%26%23xE7%3B%26%23xE3%3Bo%2C%20%26%23xE9%3B%20mostrado%20na%20Figura%201%2C%20para%20os%20resultados%20combinados%20de%205%20estudos%20de%20dose%20fixa%2C%20de%26%23xA0%3Bdose-resposta%26%23xA0%3Bde%20mais%20de%20um%20m%26%23xEA%3Bs%20de%20dura%26%23xE7%3B%26%23xE3%3Bo%2C%20mostrando%20a%20resposta%20de%20acordo%20com%20a%20fun%26%23xE7%3B%26%23xE3%3Bo%20no%20per%26%23xED%3Bodo%20basal%20(baseline).%20Os%20resultados%20com%20todas%20as%20doses%20foram%20combinados%2C%20mas%20os%20escores%20mostraram%20melhoras%20maiores%20com%20as%20doses%20de%2050%20e%20100mg%20do%20que%20com%2025mg.%20O%20padr%26%23xE3%3Bo%20de%20respostas%20foi%20semelhante%20para%20a%20outra%20quest%26%23xE3%3Bo%20principal%2C%20a%20capacidade%20de%20obter%20ere%26%23xE7%3B%26%23xE3%3Bo%20suficiente%20para%20a%20rela%26%23xE7%3B%26%23xE3%3Bo%20sexual.%20Os%20estudos%20de%20titula%26%23xE7%3B%26%23xE3%3Bo%2C%20nos%20quais%20a%20maioria%20dos%20pacientes%20recebeu%20100mg%2C%20mostraram%20resultados%20semelhantes.%3C%2Fp%3E%0A%3Cp%3EEfeito%20de%20citrato%20de%20sildenafila%20na%20manuten%26%23xE7%3B%26%23xE3%3Bo%20da%20ere%26%23xE7%3B%26%23xE3%3Bo%20por%20escore%20no%20per%26%23xED%3Bodo%20basal%20(baseline).%3C%2Fp%3E%0A%3Cp%3EEfeito%20de%20placebo%20na%20manuten%26%23xE7%3B%26%23xE3%3Bo%20da%20ere%26%23xE7%3B%26%23xE3%3Bo%20por%20escore%20no%20per%26%23xED%3Bodo%20basal%20(baseline).%3C%2Fp%3E%0A%3Cp%3EOs%20pacientes%20nos%20estudos%20tiveram%20v%26%23xE1%3Brios%20graus%20de%20DE.%20De%20um%20ter%26%23xE7%3Bo%20a%20metade%20dos%20pacientes%20nestes%20estudos%20relatou%20rela%26%23xE7%3B%26%23xF5%3Bes%20sexuais%20bem%20sucedidas%20pelo%20menos%20uma%20vez%20durante%20um%20per%26%23xED%3Bodo%20inicial%26%23xA0%3B(run-in)%26%23xA0%3Bsem%20tratamento%2C%20de%204%20semanas.%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3EEm%20muitos%20dos%20estudos%2C%20tanto%20de%20desenho%20de%20dose%20fixa%2C%20quanto%20de%20titula%26%23xE7%3B%26%23xE3%3Bo%2C%20foram%20preenchidos%20di%26%23xE1%3Brios%20pelos%20pacientes.%20Nestes%20estudos%2C%20envolvendo%20cerca%20de%201600%20pacientes%2C%20as%20an%26%23xE1%3Blises%20dos%20di%26%23xE1%3Brios%20dos%20pacientes%20n%26%23xE3%3Bo%20mostraram%20nenhum%20efeito%20de%20citrato%20de%20sildenafila%20no%20n%26%23xFA%3Bmero%20de%20tentativas%20de%20rela%26%23xE7%3B%26%23xF5%3Bes%20sexuais%20(cerca%20de%202%20por%20sema%20na)%2C%20mas%20houve%20uma%20clara%20melhora%20relacionada%20%26%23xE0%3B%20fun%26%23xE7%3B%26%23xE3%3Bo%20sexual%3A%20as%20taxas%20de%20sucesso%20semanais%20por%20paciente%20foram%20em%20m%26%23xE9%3Bdia%20de%201%2C3%20com%2050-%20100mg%20de%20citrato%20de%20sildenafila%26%23xA0%3B%3Cem%3Evs%3C%2Fem%3E.%200%2C4%20com%20placebo%3B%20de%20modo%20semelhante%2C%20as%20taxas%20m%26%23xE9%3Bdias%20de%20sucesso%20por%20grupo%20(total%20de%20sucessos%20dividido%20pelo%20total%20de%20tentativas)%20foram%20de%20cerca%20de%2066%25%20com%20citrato%20de%20sildenafila%26%23xA0%3B%3Cem%3Evs%3C%2Fem%3E.%20cerca%20de%2020%25%20com%20placebo.%3C%2Fp%3E%0A%3Cp%3EDurante%203%20a%206%20meses%20de%20tratamento%26%23xA0%3Bduplo-cego%26%23xA0%3Bou%20estudos%20abertos%20de%20longo%20prazo%20(1%20ano)%20poucos%20pacientes%20sa%26%23xED%3Bram%20do%20tratamento%20ativo%20por%20algum%20motivo%2C%20incluindo%20falta%20de%20efic%26%23xE1%3Bcia.%20No%20final%20do%20estudo%20de%20longo%20prazo%2C%2088%25%20dos%20pacientes%20relataram%20que%20citrato%20de%20sildenafila%20tinha%20melhorado%20as%20suas%20ere%26%23xE7%3B%26%23xF5%3Bes.%3C%2Fp%3E%0A%3Cp%3EHomens%20com%20DE%20n%26%23xE3%3Bo%20tratada%20tiveram%20escores%20do%20per%26%23xED%3Bodo%20basal%20(baseline)%20relativamente%20baixos%20para%20todos%20os%20aspectos%20da%20fun%26%23xE7%3B%26%23xE3%3Bo%20sexual%20medidos%20(ut%20ilizando%20uma%20escala%20de%205%20pontos)%20no%20IIEF.%20O%20citrato%20de%20sildenafila%20melhorou%20estes%20aspectos%20da%20fun%26%23xE7%3B%26%23xE3%3Bo%20sexual%3A%20frequ%26%23xEA%3Bncia%2C%20rigidez%20e%20manuten%26%23xE7%3B%26%23xE3%3Bo%20de%20ere%26%23xE7%3B%26%23xF5%3Bes%2C%20frequ%26%23xEA%3Bncia%20de%20orgasmos%3B%20frequ%26%23xEA%3Bncia%20e%20n%26%23xED%3Bvel%20de%20desejo%3B%20frequ%26%23xEA%3Bncia%2C%20satisfa%26%23xE7%3B%26%23xE3%3Bo%20e%20prazer%20na%20rela%26%23xE7%3B%26%23xE3%3Bo%20sexual%3B%20e%20satisfa%26%23xE7%3B%26%23xE3%3Bo%20geral%20no%20relacionamento.%3C%2Fp%3E%0A%3Cp%3EUm%20estudo%20randomizado%2C%26%23xA0%3Bduplo-cego%2C%26%23xA0%3Bde%20doses%20flex%26%23xED%3Bveis%2C%26%23xA0%3Bplacebo-controlado%26%23xA0%3Bincluiu%20somente%20pacientes%20com%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20atribu%26%23xED%3Bda%20a%20complica%26%23xE7%3B%26%23xF5%3Bes%20do%20diabetes%20mellitus%20(n%3D268).%20Como%20nos%20outros%20estudos%20de%20titula%26%23xE7%3B%26%23xE3%3Bo%2C%20os%20pacientes%20eram%20iniciados%20com%2050mg%20e%20podiam%20ajustar%20a%20sua%20dose%20para%20cima%20para%20100mg%20ou%20para%20baixo%20para%2025mg%20de%20citrato%20de%20sildenafila.%20Todos%20os%20pacientes%2C%20entretanto%2C%20estavam%20recebendo%2050mg%20ou%20100mg%20no%20final%20do%20estudo.%20Houve%20uma%20melhora%20estatisticamente%20significativa%20nas%20duas%20principais%20quest%26%23xF5%3Bes%20do%20IIEF%20(frequ%26%23xEA%3Bncia%20de%20penetra%26%23xE7%3B%26%23xE3%3Bo%26%23xA0%3Bbem-sucedida%26%23xA0%3Bdurante%20a%20atividade%20sexual%20e%20manuten%26%23xE7%3B%26%23xE3%3Bo%20das%20ere%26%23xE7%3B%26%23xF5%3Bes%20ap%26%23xF3%3Bs%20a%20penetra%26%23xE7%3B%26%23xE3%3Bo)%20com%20citrato%20de%20sildenafila%20comparado%20com%20placebo.%20Numa%20quest%26%23xE3%3Bo%20de%20melhora%20global%2C%2057%25%20dos%20pacientes%20de%20citrato%20de%20sildenafila%20relataram%20ere%26%23xE7%3B%26%23xF5%3Bes%20melhores%20contra%2010%25%20dos%20pacientes%20de%20placebo.%20Os%20dados%20dos%20di%26%23xE1%3Brios%20indicaram%20que%20com%20citrato%20de%20sildenafila%2C%2048%25%20das%20tentativas%20de%20rela%26%23xE7%3B%26%23xF5%3Bes%20sexuais%20foram%26%23xA0%3Bbem-sucedidas%26%23xA0%3B%3Cem%3Eversus%26%23xA0%3B%3C%2Fem%3E12%25%20com%20placebo.%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3EFoi%20conduzido%20um%20estudo%20randomizado%2C%26%23xA0%3Bduplo-cego%2C%26%23xA0%3Bplacebo-controlado%2C%26%23xA0%3Bde%20doses%20flex%26%23xED%3Bveis%20(at%26%23xE9%3B%20100mg)%20de%20pacientes%20com%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20resultante%20de%20les%26%23xE3%3Bo%20da%20medula%20espinal%20(n%3D178).%20As%20altera%26%23xE7%3B%26%23xF5%3Bes%20do%20per%26%23xED%3Bodo%20basal%20(baseline)%20nos%20escores%20de%20duas%20quest%26%23xF5%3Bes%20de%20desfecho%20(frequ%26%23xEA%3Bncia%20de%20penetra%26%23xE7%3B%26%23xE3%3Bo%26%23xA0%3Bbem-sucedida%26%23xA0%3Bdurante%20a%20atividade%20sexual%20e%20manuten%26%23xE7%3B%26%23xE3%3Bo%20das%20ere%26%23xE7%3B%26%23xF5%3Bes%20ap%26%23xF3%3Bs%20a%20penetra%26%23xE7%3B%26%23xE3%3Bo)%20foram%20altamente%20estatisticamente%20significativas%20em%20favor%20de%20citrato%20de%20sildenafila.%20Numa%20quest%26%23xE3%3Bo%20de%20melhora%20global%2C%2083%25%20dos%20pacientes%20relataram%20ere%26%23xE7%3B%26%23xF5%3Bes%20melhores%20com%20citrato%20de%20sildenafila%20versus%2012%25%20com%20placebo.%20Os%20dados%20dos%20di%26%23xE1%3Brios%20indicaram%20que%20com%20citrato%20de%20sildenafila%2C%2059%25%20das%20tentativas%20de%20rela%26%23xE7%3B%26%23xF5%3Bes%20sexuais%20foram%26%23xA0%3Bbem-sucedidas%26%23xA0%3Bem%20compara%26%23xE7%3B%26%23xE3%3Bo%20com%2013%25%20com%20placebo.%3C%2Fp%3E%0A%3Cp%3EEm%20todos%20os%20ensaios%2C%20citrato%20de%20sildenafila%20melhorou%20as%20ere%26%23xE7%3B%26%23xF5%3Bes%20de%2043%25%20de%20pacientes%20de%20prostatectomia%20radical%20comparado%20a%2015%25%20com%20placebo.%3C%2Fp%3E%0A%3Cp%3EAs%20an%26%23xE1%3Blises%20de%20subgrupo%20de%20respostas%20a%20uma%20quest%26%23xE3%3Bo%20de%20melhora%20global%20em%20pacientes%20com%20etiologia%20psicog%26%23xEA%3Bnica%20em%20dois%20estudos%20de%20dose%20fixa(n%20total%20%3D%20179)%20e%20dois%20estudos%20de%20titula%26%23xE7%3B%26%23xE3%3Bo%20(n%20total%20%3D%20149)%20mostraram%20que%2084%25%20dos%20pacientes%20de%20citrato%20de%20sildenafila%20relataram%20melhoras%20nas%20ere%26%23xE7%3B%26%23xF5%3Bes%20comparado%20com%2026%25%20dos%20pacientes%20de%20placebo.%20A%20altera%26%23xE7%3B%26%23xE3%3Bo%20do%20per%26%23xED%3Bodo%20basal%20(baseline)%20nos%20escores%20nas%20duas%20quest%26%23xF5%3Bes%20de%20desfecho%20(frequ%26%23xEA%3Bncia%20de%20penetra%26%23xE7%3B%26%23xE3%3Bo%26%23xA0%3Bbem-sucedida%26%23xA0%3Bdurante%20a%20atividade%20sexual%20e%20manuten%26%23xE7%3B%26%23xE3%3Bo%20de%20ere%26%23xE7%3B%26%23xF5%3Bes%20ap%26%23xF3%3Bs%20a%20penetra%26%23xE7%3B%26%23xE3%3Bo)%20foi%20estatisticamente%20significativa%20em%20favor%20de%20citrato%20de%20sildenafila.%20Os%20dados%20de%20di%26%23xE1%3Brios%20em%20dois%20dos%20estudos%20(n%3D178)%20mostraram%20taxas%20de%20rela%26%23xE7%3B%26%23xF5%3Bes%20sexuais%26%23xA0%3Bbem-sucedidas%26%23xA0%3Bpor%20tentativa%20de%2070%25%20para%20citrato%20de%20sildenafila%20e%2029%25%20para%20placebo.%3C%2Fp%3E%0A%3Cp%3EUma%20revis%26%23xE3%3Bo%20de%20subgrupos%20populacionais%20demonstrou%20efic%26%23xE1%3Bcia%20independente%20da%20gravidade%2C%20etiologia%2C%20ra%26%23xE7%3Ba%20e%20idade%20no%20per%26%23xED%3Bodo%20basal%20(baseline)%20.%20O%20citrato%20de%20sildenafila%20foi%20efetivo%20numa%20ampla%20faixa%20de%20pacientes%20com%20DE%2C%20incluindo%20aqueles%20com%20uma%20hist%26%23xF3%3Bria%20de%20doen%26%23xE7%3Ba%20arterial%20coronariana%2C%20hipertens%26%23xE3%3Bo%2C%20outras%20doen%26%23xE7%3Bas%20card%26%23xED%3Bacas%2C%20doen%26%23xE7%3Ba%20vascular%20perif%26%23xE9%3Brica%2C%20diabetes%20mellitus%2C%20depress%26%23xE3%3Bo%2C%20revasculariza%26%23xE7%3B%26%23xE3%3Bo%20mioc%26%23xE1%3Brdica%2C%20prostatectomia%20radical%2C%20ressec%26%23xE7%3B%26%23xE3%3Bo%20transuretral%20da%20pr%26%23xF3%3Bstata%20(RTUP)%2C%20les%26%23xE3%3Bo%20da%20medula%20espinal%20e%20em%20pacientes%20em%20tratamento%20com%20antidepressivos%2Fantipsic%26%23xF3%3Bticos%20e%20anti-%20hipertensivos%2Fdiur%26%23xE9%3Bticos.%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3EA%20an%26%23xE1%3Blise%20dos%20dados%20de%20seguran%26%23xE7%3Ba%20n%26%23xE3%3Bo%20mostrou%20nenhuma%20diferen%26%23xE7%3Ba%20aparente%20no%20perfil%20de%20efeitos%20colaterais%20em%20pacientes%20tomando%20citrato%20de%20sildenafila%20com%20e%20sem%20medica%26%23xE7%3B%26%23xE3%3Bo%26%23xA0%3Banti-hipertensiva.%20Esta%20an%26%23xE1%3Blise%20foi%20realizada%20retrospectivamente%20e%20n%26%23xE3%3Bo%20tinha%20poder%20para%20detectar%20qualquer%20diferen%26%23xE7%3Ba%26%23xA0%3Bpr%26%23xE9%3B-especificada%26%23xA0%3Bem%20rea%26%23xE7%3B%26%23xF5%3Bes%20adversas.%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3E%20CARACTER%26%23xCD%3BSTICAS%20FARMACOL%26%23xD3%3BGICAS%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EPropriedades%20Farmacodin%26%23xE2%3Bmicas%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3EA%20sildenafila%20sob%20a%20forma%20de%20sal%20citrato%2C%20%26%23xE9%3B%20uma%20terapia%20oral%20para%20a%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil.%20A%20sildenafila%20%26%23xE9%3B%20um%20inibidor%20seletivo%20da%20fosfodiesterase%20tipo%205%20(PDE5)%2C%20espec%26%23xED%3Bfica%20do%20monofosfato%20de%20guanosina%20c%26%23xED%3Bclico%20(GMPc).%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3E%3Cstrong%3EMecanismo%20de%20A%26%23xE7%3B%26%23xE3%3Bo%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3EO%20mecanismo%20fisiol%26%23xF3%3Bgico%20respons%26%23xE1%3Bvel%20pela%20ere%26%23xE7%3B%26%23xE3%3Bo%20do%20p%26%23xEA%3Bnis%20envolve%20a%20libera%26%23xE7%3B%26%23xE3%3Bo%20de%20%26%23xF3%3Bxido%20n%26%23xED%3Btrico%20nos%20corpos%20cavernosos%20durante%20a%20estimula%26%23xE7%3B%26%23xE3%3Bo%20sexual.%20O%20%26%23xF3%3Bxido%20n%26%23xED%3Btrico%2C%20ent%26%23xE3%3Bo%2C%20ativa%20a%20enzima%20guanilato%20ciclase%2C%20que%20resulta%20no%20aumento%20dos%20n%26%23xED%3Bveis%20de%20monofosfato%20de%20guanosina%20c%26%23xED%3Bclico%20(GMPc)%2C%20produzindo%20um%20relaxamento%20da%20musculatura%20lisa%20dos%20corpos%20cavernosos%2C%20permitindo%20o%20influxo%20de%20sangue.%20A%20sildenafila%20n%26%23xE3%3Bo%20exerce%20um%20efeito%20relaxante%20diretamente%20sobre%20os%20corpos%20cavernosos%20isolados%20de%20humanos%2C%20mas%20melhora%20o%20efeito%20do%20%26%23xF3%3Bxido%20n%26%23xED%3Btrico%20atrav%26%23xE9%3Bs%20da%20inibi%26%23xE7%3B%26%23xE3%3Bo%20da%20fosfodiesterase%20tipo%205%20(PDE5)%2C%20a%20qual%20%26%23xE9%3B%20respons%26%23xE1%3Bvel%20pela%20degrada%26%23xE7%3B%26%23xE3%3Bo%20do%20GMPc%20nos%20corpos%20cavernosos.%20Quando%20a%20estimula%26%23xE7%3B%26%23xE3%3Bo%20sexual%20causa%20a%20libera%26%23xE7%3B%26%23xE3%3Bo%20local%20de%20%26%23xF3%3Bxido%20n%26%23xED%3Btrico%2C%20a%20inibi%26%23xE7%3B%26%23xE3%3Bo%20da%20PDE5%20causada%20pela%20sildenafila%20aumenta%20os%20n%26%23xED%3Bveis%20de%20GMPc%20nos%20corpos%20cavernosos%2C%20resultando%20no%20relaxamento%20da%20musculatura%20lisa%20e%20no%20influxo%20de%20sangue%20nos%20corpos%20cavernosos.%20A%20sildenafila%2C%20nas%20doses%20recomendadas%2C%20n%26%23xE3%3Bo%20exerce%20qualquer%20efeito%20na%20aus%26%23xEA%3Bncia%20de%20estimula%26%23xE7%3B%26%23xE3%3Bo%20sexual.%20Estudos%26%23xA0%3B%3Cem%3Ein%20vitro%26%23xA0%3B%3C%2Fem%3Emostraram%20que%20a%20sildenafila%20%26%23xE9%3B%20seletiva%20para%20a%20PDE5.Seu%20efeito%20%26%23xE9%3B%20mais%20potente%20para%20a%20PDE5%20quando%20comparado%20a%20outras%20fosfodiesterases%20conhecidas%20(10%20vezes%20para%20a%20PDE6%2C%20%26gt%3B%2080%20vezes%20para%20a%20PDE1%20e%20%26gt%3B%20700%20vezes%20para%20a%20PDE2%2C%20PDE3%2C%20PDE4%2C%20PDE7%20e%20PDE11).%20A%20seletividade%20da%20sildenafila%2C%20aproximadamente%204000%20vezes%20maior%20para%20a%20PDE5%20versus%20a%20PDE3%2C%20%26%23xE9%3B%20importante%2C%20uma%20vez%20que%20a%20PDE3%20est%26%23xE1%3B%20envolvida%20no%20controle%20da%20contratilidade%20card%26%23xED%3Baca.%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EEstudos%20Cl%26%23xED%3Bnicos%20Card%26%23xED%3Bacos%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3EN%26%23xE3%3Bo%20foram%20observadas%20altera%26%23xE7%3B%26%23xF5%3Bes%20clinicamente%20significativas%20no%20ECG%20de%20volunt%26%23xE1%3Brios%20sadios%20do%20sexo%20masculino%20que%20receberam%20doses%20%26%23xFA%3Bnicas%20orais%20de%20sildenafila%20de%20at%26%23xE9%3B%20100mg.%20O%20valor%20m%26%23xE1%3Bximo%20m%26%23xE9%3Bdio%20de%20redu%26%23xE7%3B%26%23xE3%3Bo%20da%20press%26%23xE3%3Bo%20arterial%20sist%26%23xF3%3Blica%20na%20posi%26%23xE7%3B%26%23xE3%3Bo%20supina%2C%20ap%26%23xF3%3Bs%20uma%20dose%20oral%20de%20100mg%2C%20foi%20de%208%2C3mm%20Hg.%20O%20valor%20correspondente%20da%20press%26%23xE3%3Bo%20arterial%20diast%26%23xF3%3Blica%20foi%20de%205%2C3mmHg.%20Um%20efeito%20mais%20significativo%2C%20por%26%23xE9%3Bm%2C%20igualmente%20transit%26%23xF3%3Brio%2C%20na%20press%26%23xE3%3Bo%20arterial%20foi%20observado%20em%20pacientes%20recebendo%20nitratos%20e%20citrato%20de%20sildenafila%20concomitantemente%20(vide%20item%204.%20Contraindica%26%23xE7%3B%26%23xF5%3Bes%20e%20vide%20item%206.%20Intera%26%23xE7%3B%26%23xF5%3Bes%20Medicamentosas).%20Em%20um%20estudo%20dos%20efeitos%20hemodin%26%23xE2%3Bmicos%20de%20uma%20dose%20%26%23xFA%3Bnica%20oral%20de%20100mg%20de%20sildenafila%2C%20em%2014%20pacientes%20com%20doen%26%23xE7%3Ba%20arterial%20coron%26%23xE1%3Bria%20(DAC)%20grave%20(pelo%20menos%20uma%20art%26%23xE9%3Bria%20coron%26%23xE1%3Bria%20com%20estenose%20%26gt%3B%2070%25)%2C%20a%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea%20m%26%23xE9%3Bdia%20sist%26%23xF3%3Blica%20e%20diast%26%23xF3%3Blica%2C%20no%20repouso%2C%20diminuiu%207%25%20e%206%25%2C%20respectivamente%2C%20comparada%20%26%23xE0%3B%20linha%20de%20base.%20A%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea%20sist%26%23xF3%3Blica%20pulmonar%20m%26%23xE9%3Bdia%20diminuiu%209%25.%20A%20sildenafila%20n%26%23xE3%3Bo%20apresentou%20efeitos%20sobre%20o%20d%26%23xE9%3Bbito%20card%26%23xED%3Baco%2C%20n%26%23xE3%3Bo%20prejudicou%20o%20fluxo%20de%20sangue%20atrav%26%23xE9%3Bs%20das%20art%26%23xE9%3Brias%20coron%26%23xE1%3Brias%20com%20estenose%20e%20resultou%20em%20melhora%20(aproximadamente%2013%25)%20na%20reserva%20do%20fluxo%20coron%26%23xE1%3Brio%20induzido%20por%20adenosina%20tanto%20(%20nas%20art%26%23xE9%3Brias%20com%20estenose%20como%20nas%20art%26%23xE9%3Brias%20de%20refer%26%23xEA%3Bncia).%20Em%20um%20estudo%26%23xA0%3Bduplo-cego%2C%26%23xA0%3Blacebop-controlado%2C%26%23xA0%3B144%20pacientes%20com%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20e%20angina%20est%26%23xE1%3Bvel%20que%20estavam%20utilizando%20suas%20medica%26%23xE7%3B%26%23xF5%3Bes%20antianginosas%20usuais%20(com%20exce%26%23xE7%3B%26%23xE3%3Bo%20de%20nitratos)%20foram%20submetidos%20a%20exerc%26%23xED%3Bcios%20at%26%23xE9%3B%20o%20limite%20da%20ocorr%26%23xEA%3Bncia%20de%20angina.%20O%20tempo%20de%20exerc%26%23xED%3Bcio%20de%20esteira%20foi%20significativa%20e%20estatisticamente%20superior%20(19%2C9%20segundos%3B%20intervalo%20de%20confian%26%23xE7%3Ba%20de%2095%25%3A%26%23xA0%3B0%2C9%26%23x2013%3B38%2C9%26%23xA0%3Bsegundos)%20n%20os%20pacientes%20avali%26%23xE1%3Bveis%20que%20haviam%20ingerido%20uma%20dose%20%26%23xFA%3Bnica%20de%20100mg%20de%20sildenafila%2C%20em%20compara%26%23xE7%3B%26%23xE3%3Bo%20aos%20pacientes%20que%20ingeriram%20placebo%20em%20dose%20%26%23xFA%3Bnica.%20O%20per%26%23xED%3Bodo%20m%26%23xE9%3Bdio%20de%20exerc%26%23xED%3Bcio%20(ajustado%20para%20a%20linha%20de%20base)%20para%20o%20in%26%23xED%3Bcio%20da%20angina%20limitante%20foi%20de%20423%2C6%20segundos%20para%20sildenafila%20e%20de%20403%2C7%20segundos%20para%20o%20placebo.%20Foi%20realizado%20um%20estudo%20randomizado%2C%26%23xA0%3Bduplo-cego%2C%26%23xA0%3Bplacebo-controlado%2C%26%23xA0%3Bcom%20dose%20flex%26%23xED%3Bvel%20(sildenafila%20at%26%23xE9%3B%20100mg)%20em%20homens%20(n%20%3D%20568)%20com%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20e%20hipertens%26%23xE3%3Bo%20arterial%20tomando%20dois%20ou%20mais%20medicamentos%26%23xA0%3Banti-hipertensivos.%26%23xA0%3BA%20sildenafila%20melhorou%20as%20ere%26%23xE7%3B%26%23xF5%3Bes%20em%2071%25%20dos%20homens%20comparada%20a%2018%25%20no%20grupo%20que%20recebeu%20placebo%2C%20e%2062%25%20de%20tentativas%20de%20rela%26%23xE7%3B%26%23xE3%3Bo%20sexual%20bem-%20sucedidas%20no%20grupo%20que%20recebeu%20a%20sildenafila%20comparado%20a%2026%25%20no%20grupo%20que%20recebeu%20placebo.%20A%20incid%26%23xEA%3Bncia%20de%20eventos%20adversos%20foi%20consistente%20quando%20comparado%20a%20outras%20popula%26%23xE7%3B%26%23xF5%3Bes%20de%20pacientes%2C%20assim%20como%20em%20indiv%26%23xED%3Bduos%20que%20tomam%20tr%26%23xEA%3Bs%20ou%20mais%20agentes%26%23xA0%3Banti-hipertensivos.%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3E%3Cstrong%3EVisual%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3EUtilizando-se%26%23xA0%3Bo%20teste%20de%20colora%26%23xE7%3B%26%23xE3%3Bo%20de%26%23xA0%3BFarnsworth-Mu%26%23xA0%3Bnsell%20100%2C%20foi%20observado%20em%20alguns%20indiv%26%23xED%3Bduos%20altera%26%23xE7%3B%26%23xF5%3Bes%20leves%20e%20transit%26%23xF3%3Brias%20na%20distin%26%23xE7%3B%26%23xE3%3Bo%20de%20cores%20(azul%2Fverde)%2060%20minutos%20ap%26%23xF3%3Bs%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20uma%20dose%20de%20100mg%3B%20ap%26%23xF3%3Bs%20120%20minutos%20da%20administra%26%23xE7%3B%26%23xE3%3Bo%2C%20n%26%23xE3%3Bo%20foram%20observados%20efeitos%20evidentes.%20O%20mecanismo%20aceito%20para%20essa%20altera%26%23xE7%3B%26%23xE3%3Bo%20na%20distin%26%23xE7%3B%26%23xE3%3Bo%20de%20cores%20est%26%23xE1%3B%20relacionado%20%26%23xE0%3B%20inibi%26%23xE7%3B%26%23xE3%3Bo%20da%26%23xA0%3Bfosfodiesterase-6%26%23xA0%3B(PDE-6)%2C%26%23xA0%3Bque%20est%26%23xE1%3B%20envolvida%20na%20cascata%20de%20fototransdu%26%23xE7%3B%26%23xE3%3Bo%20da%20retina.%20Estudos%26%23xA0%3B%3Cem%3Ein%20vitro%26%23xA0%3B%3C%2Fem%3Edemonstram%20que%20a%20sildenafila%20%26%23xE9%3B%2010%20vezes%20menos%20potente%20na%20PDE6%20do%20que%20na%20PDE5.%20A%20sildenafila%20n%26%23xE3%3Bo%20exerce%20efeitos%20sobre%20a%20acuidade%20visual%2C%20sensibilidade%20de%20contrastes%2C%20eletroretinogramas%2C%20press%26%23xE3%3Bo%20intraocular%20ou%20pupilome%20tria.%20Um%20estudo%20cl%26%23xED%3Bnico%20cruzado%2C%20placebo-%20controlado%2C%20com%20pacientes%20com%20degenera%26%23xE7%3B%26%23xE3%3Bo%20macular%20precoce%20comprovadamente%20relacionada%20%26%23xE0%3B%20idade%20(n%20%3D%209)%2C%20demonstrou%20que%20a%20sildenafila%20(dose%20%26%23xFA%3Bnica%20de%20100mg)%20foi%20bem%20tolerada%20e%20n%26%23xE3%3Bo%20demostrou%20altera%26%23xE7%3B%26%23xF5%3Bes%20clinicamente%20significativas%20no%20s%20testes%20visuais%20conduzidos%20(acuidade%20visual%2C%20escala%20de%20Amsler%2C%20discrimina%26%23xE7%3B%26%23xE3%3Bo%20de%20cores%2C%20simula%26%23xE7%3B%26%23xE3%3Bo%20de%20luzes%20de%20tr%26%23xE2%3Bnsito%2C%20per%26%23xED%3Bmetro%20de%20Humphrey%20e%20foto%20estresse).%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EPropriedades%20Farmacocin%26%23xE9%3Bticas%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3EA%20sildenafila%20apresenta%20uma%20farmacocin%26%23xE9%3Btica%26%23xA0%3Bdose-proporcional%2C%26%23xA0%3Bdentro%20do%20intervalo%20de%20doses%20recomendadas.%20A%20sildenafila%20%26%23xE9%3B%20eliminada%20predominantemente%20atrav%26%23xE9%3Bs%20do%20metabolismo%20hep%26%23xE1%3Btico%20(principalmente%20via%20citocromo%20P450%203A4)%2C%20e%20%26%23xE9%3B%20convertida%20a%20um%20metab%26%23xF3%3Blito%20ativo%20com%20propriedades%20semelhantes%20%26%23xE0%3B%20sildenafila%20inalterada.%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3E%3Cstrong%3EAbsor%26%23xE7%3B%26%23xE3%3Bo%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3EA%20sildenafila%20%26%23xE9%3B%20rapidamente%20absorvida%20ap%26%23xF3%3Bs%20administra%26%23xE7%3B%26%23xE3%3Bo%20oral%2C%20apresentando%20uma%20biodisponibilidade%20absoluta%20m%26%23xE9%3Bdia%20de%2041%25%20(variando%20entre%2025%20%26%23x2013%3B%2063%25).%20A%20sildenafila%2C%20a%20uma%20concentra%26%23xE7%3B%26%23xE3%3Bo%20equivalente%20a%203%2C5nM%2C%20inibe%20em%2050%25%20a%20atividade%20da%20enzima%20humana%20PDE5%2C%26%23xA0%3B%3Cem%3Ein%20vitro%3C%2Fem%3E.%20Em%20homens%2C%20a%20m%26%23xE9%3Bdia%20da%20concentra%26%23xE7%3B%26%23xE3%3Bo%20plasm%26%23xE1%3Btica%20m%26%23xE1%3Bxima%20de%20sildenafila%20livre%2C%20ap%26%23xF3%3Bs%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20uma%20dose%20%26%23xFA%3Bnica%20oral%20de%20100mg%2C%20%26%23xE9%3B%20de%20aproximadamente%2018ng%2FmL%20ou%2038nM.%20As%20concentra%26%23xE7%3B%26%23xF5%3Bes%20plasm%26%23xE1%3Bticas%20m%26%23xE1%3Bximas%20observadas%20s%26%23xE3%3Bo%20atingidas%20de%2030%20a%20120%20minutos%20(em%20m%26%23xE9%3Bdia%2060%20minutos)%20ap%26%23xF3%3Bs%20uma%20dose%20oral%2C%20em%20jejum.%20Quando%20a%20sil%20denafila%20%26%23xE9%3B%20administrada%20com%20uma%20refei%26%23xE7%3B%26%23xE3%3Bo%20rica%20em%20l%26%23xED%3Bpides%2C%20a%20taxa%20de%20absor%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE9%3B%20reduzida%2C%20verificando-se%26%23xA0%3Bum%20atraso%20m%26%23xE9%3Bdio%20de%2060%20minutos%20no%20Tm%26%23xE1%3Bx%26%23xA0%3Be%20uma%20redu%26%23xE7%3B%26%23xE3%3Bo%20m%26%23xE9%3Bdia%20de%2029%25%20na%20C%26%23xA0%3Bm%26%23xE1%3Bx%2C%20contudo%2C%20a%20extens%26%23xE3%3Bo%20de%20absor%26%23xE7%3B%26%23xE3%3Bo%20n%26%23xE3%3Bo%20foi%20significativamente%20afetada%20(AUC%20reduzida%20em%2011%25).%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EDistribui%26%23xE7%3B%26%23xE3%3Bo%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3EO%20volume%20m%26%23xE9%3Bdio%20de%20distribui%26%23xE7%3B%26%23xE3%3Bo%20da%20sildenafila%20no%20estado%20de%20equil%26%23xED%3Bbrio%20(Vss)%26%23xA0%3B(steady-state)%26%23xA0%3B%26%23xE9%3B%20de%20105%20litros%2C%20indicando%20sua%20distribui%26%23xE7%3B%26%23xE3%3Bo%20nos%20tecidos.%20A%20sildenafila%20e%20o%20seu%20principal%20metab%26%23xF3%3Blito%20circulante%2C%20o%26%23xA0%3BN-desmetil%2C%26%23xA0%3Bapresentam%20uma%20liga%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE0%3Bs%20prote%26%23xED%3Bnas%20plasm%26%23xE1%3Bticas%20de%20aproximadamente%2096%25.%20A%20liga%26%23xE7%3B%26%23xE3%3Bo%20proteica%20%26%23xE9%3B%20independente%20da%20concentra%26%23xE7%3B%26%23xE3%3Bo%20total%20do%20f%26%23xE1%3Brmaco.%20Com%20base%20nas%20medidas%20de%20sildenafila%20no%20s%26%23xEA%3Bmen%20de%20volunt%26%23xE1%3Brios%20sadios%2C%20foi%20demonstrado%20que%20menos%20de%200%2C0002%25%20(em%20m%26%23xE9%3Bdia%20188ng)%20da%20dose%20administrada%20estava%20presente%20no%20s%26%23xEA%3Bmen%20dos%20pacientes%2C%2090%20minutos%20ap%26%23xF3%3Bs%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20do%20f%26%23xE1%3Brmaco.%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3E%3Cstrong%3EMetabolismo%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3EA%20sildenafila%20sofre%20depura%26%23xE7%3B%26%23xE3%3Bo%20hep%26%23xE1%3Btica%20principalmente%20pelas%20isoenzimas%20microssomais%20CYP3A4%20(via%20principal)%20e%20CYP2C9%20(via%20secund%26%23xE1%3Bria).%20O%20principal%20metab%26%23xF3%3Blito%20circulante%2C%20que%20mais%20tarde%20tamb%26%23xE9%3Bm%20%26%23xE9%3B%20metabolizado%2C%20resulta%20da%26%23xA0%3BN-desmetila%26%23xE7%3B%26%23xE3%3Bo%26%23xA0%3Bda%20sildenafila.%20Esse%20metab%26%23xF3%3Blito%20apresenta%20perfil%20de%20seletividade%20para%20as%20PDE%20semelhante%20a%20da%20sildenafila%20e%20pot%26%23xEA%3Bncia%20de%20inibi%26%23xE7%3B%26%23xE3%3Bo%26%23xA0%3B%3Cem%3Ein%20vitro%26%23xA0%3B%3C%2Fem%3Epara%20a%20PDE5%20de%20aproximadamente%2050%25%20da%20verificada%20para%20o%20f%26%23xE1%3Brmaco%20inalterado.%20As%20concentra%26%23xE7%3B%26%23xF5%3Bes%20plasm%26%23xE1%3Bticas%20desse%20metab%26%23xF3%3Blito%20s%26%23xE3%3Bo%20de%20aproximadamente%2040%25%20da%20verificada%20para%20a%20sildenafila%20em%20volunt%26%23xE1%3Brios%20sadios.%20O%20metab%26%23xF3%3Blito%26%23xA0%3BN-desmetil%26%23xA0%3B%26%23xE9%3B%20amplamente%20metabolizado%2C%20apresentando%26%23xA0%3Bmeia-vida%26%23xA0%3Bterminal%20de%20aproximadamente%204%20h.%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EElimina%26%23xE7%3B%26%23xE3%3Bo%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3EO%20clearance%20total%20da%20sildenafila%20%26%23xE9%3B%20de%2041L%2Fh%2C%20com%26%23xA0%3Bmeia-vida%26%23xA0%3Bterminal%20de%26%23xA0%3B3-5%26%23xA0%3Bhoras.%20Ap%26%23xF3%3Bs%20administra%26%23xE7%3B%26%23xE3%3Bo%20oral%20ou%20intravenosa%2C%20a%20sildenafila%20%26%23xE9%3B%20excretada%20sob%20a%20forma%20de%20metab%26%23xF3%3Blitos%2C%20predominantemente%20nas%20fezes%20(aproximadamente%2080%25%20da%20dose%20oral%20administrada)%20e%20em%20menor%20quantidade%20na%20urina%20(aproximadamente%2013%25%20da%20dose%20oral%20administrada).%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3E%3Cstrong%3EFarmacocin%26%23xE9%3Btica%20em%20Grupos%20de%20Pacientes%20Especiais%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EIdosos%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3EVolunt%26%23xE1%3Brios%20sadios%20idosos%20(65%20anos%20ou%20mais)%20apresentaram%20uma%20redu%26%23xE7%3B%26%23xE3%3Bo%20no%20clearance%20da%20sildenafila%2C%20resultando%20em%20concentra%26%23xE7%3B%26%23xF5%3Bes%20plasm%26%23xE1%3Bticas%20aproximadamente%2090%25%20maiores%20de%20sildenafila%20e%20o%20metab%26%23xF3%3Blito%20ativo%26%23xA0%3BN-desmetil%26%23xA0%3Bcompara%20do%20%26%23xE0%3Bquelas%20observadas%20em%20volunt%26%23xE1%3Brios%20sadios%20mais%20jovens%26%23xA0%3B(18-45%26%23xA0%3Banos).%20Devido%20a%20diferen%26%23xE7%3Bas%20de%20id%20ade%20na%20liga%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE0%3Bs%20prote%26%23xED%3Bnas%20plasm%26%23xE1%3Bticas%2C%20o%20aumento%20correspondente%20na%20concentra%26%23xE7%3B%26%23xE3%3Bo%20plasm%26%23xE1%3Btica%20da%20sildenafila%20livre%20foi%20de%20aproximadamente%2040%25.%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EInsufici%26%23xEA%3Bncia%20Renal%3C%2Fstrong%3E%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3EEm%20volunt%26%23xE1%3Brios%20com%20insufici%26%23xEA%3Bncia%20renal%20leve%20(clearance%20de%20creatinina%20%3D%26%23xA0%3B50-80mL%2Fmin)%26%23xA0%3Be%20moderada%20(clearance%20de%20creatinina%20%3D%26%23xA0%3B30-49mL%2Fmin)%2C%26%23xA0%3Ba%20farmacocin%26%23xE9%3Btica%20a%20uma%20dose%20%26%23xFA%3Bnica%20oral%20de%20sildenafila%20(50mg)%20n%26%23xE3%3Bo%20foi%20alterada.%20Em%20volunt%26%23xE1%3Brios%20com%20insufici%26%23xEA%3Bncia%20renal%20grave%20(clearance%20de%20creatinina%26%23xA0%3B%26%23x2264%3B%26%23xA0%3B30mL%2Fmin)%2C%20o%20clearance%20da%20sildenafila%20se%20mostrou%20reduzido%2C%20resultando%20em%20um%20aumento%20da%20AUC%20(100%25)%20e%20da%20Cm%26%23xE1%3Bx(88%25)%2C%20comparado%20com%20indiv%26%23xED%3Bduos%20de%20idade%20semelhante%2C%20sem%20insufici%26%23xEA%3Bncia%20renal%20(vide%20item%208.%20Posologia%20e%20Modo%20de%20usar).%20Al%26%23xE9%3Bm%20disso%2C%20os%20valores%20da%20AUC%20e%20Cm%26%23xE1%3Bx%26%23xA0%3Bdo%20metab%26%23xF3%3Blito%26%23xA0%3BN-desmetil%26%23xA0%3Bforam%20significativamente%20aumentados%20em%20200%25%20e%2079%25%2C%20respectivamente%2C%20em%20indiv%26%23xED%3Bduos%20com%20insufici%26%23xEA%3Bncia%20renal%20grave%20comparado%20a%20indiv%26%23xED%3Bduos%20com%20fun%26%23xE7%3B%26%23xE3%3Bo%20renal%20normal.%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EInsufici%26%23xEA%3Bncia%20Hep%26%23xE1%3Btica%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3EEm%20volunt%26%23xE1%3Brios%20com%20cirrose%20hep%26%23xE1%3Btica%20(classe%20A%20e%26%23xA0%3BBedChild-Pugh)%26%23xA0%3Bo%20clearance%20da%20sildenafila%20foi%20reduzido%2C%20resultando%20em%20um%20aumento%20da%20AUC%20(85%25)%20e%20da%20Cm%26%23xE1%3Bx%26%23xA0%3B(47%25)%2C%20comparado%20com%20indiv%26%23xED%3Bduos%20de%20idade%20semelhante%2C%20sem%20insufici%26%23xEA%3Bncia%20hep%26%23xE1%3Btica%20(vide%20item%208.%20Posologia%20e%20Modo%20de%20usar).%20A%20farmacocin%26%23xE9%3Btica%20da%20sildenafila%20em%20pacientes%20com%20insufici%26%23xEA%3Bncia%20hep%26%23xE1%3Btica%20grave%20(classe%20C%20de%26%23xA0%3BChild-Pugh)%26%23xA0%3Bn%26%23xE3%3Bo%20foi%20estudada.%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EDados%20de%20Seguran%26%23xE7%3Ba%26%23xA0%3BPr%26%23xE9%3B-cl%26%23xED%3Bnicos%3C%2Fstrong%3E%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3ENenhuma%20evid%26%23xEA%3Bncia%20de%20carcinogenicidade%20relacionada%20com%20a%20droga%20foi%20revelado%20em%20um%20estudo%20de%2024%20meses%20em%20ratos%20com%20doses%20at%26%23xE9%3B%2042%20vezes%20a%20dose%20m%26%23xE1%3Bxima%20recomendada%20para%20humanos%20(DMRH)%20em%20uma%20base%20de%20mg%2Fkg%20e%20cerca%20de%20cinco%20vezes%20a%20DMRH%20em%20uma%20base%20mg%2Fm2%26%23xA0%3Be%20em%20um%20estudo%20de%26%23xA0%3B18-21%26%23xA0%3Bmeses%20em%20camundongos%20com%20doses%20at%26%23xE9%3B%2021%20vezes%20a%20DMRH%20em%20uma%20base%20de%20mg%2Fkg%3C%2Fp%3E%0A%3Cp%3E(aproximadamente%20duas%20vezes%20a%20DMRH%20com%20base%20em%20mg%2Fm2).%20Testes%20bacterianos%20e%20de%20mutagenicidade%26%23xA0%3B%3Cem%3Ein%20vivo%26%23xA0%3B%3C%2Fem%3Eforam%20negativos.%3C%2Fp%3E%0A%3Cp%3EN%26%23xE3%3Bo%20houve%20efeito%20sobre%20a%20motilidade%20ou%20morfologia%20d%20o%20espermatozoide%20ap%26%23xF3%3Bs%20dose%20%26%23xFA%3Bnica%20oral%20de%20100%20mg%20de%20sildenafila%20em%20volunt%26%23xE1%3Brios%20sadios.%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3E%20CONTRAINDICA%26%23xC7%3B%26%23xD5%3BES%3C%2Fstrong%3E%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3EO%20uso%20do%20citrato%20de%20sildenafila%20est%26%23xE1%3B%20contraindicado%20a%20pacientes%20com%20hipersensibilidade%20conhecida%20ao%20f%26%23xE1%3Brmaco%20ou%20a%20qualquer%20componente%20da%20f%26%23xF3%3Brmula.%20Foi%20demonstrado%20que%20o%20citrato%20de%20sildenafila%20potencializa%20o%20efeito%20hipotensor%20dos%20nitratos%20de%20uso%20agudo%20ou%20cr%26%23xF4%3Bnico%2C%20estando%2C%20portanto%2C%20contraindicada%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20a%20pacientes%20que%20este%20jam%20usando%20concomitantemente%20qualquer%20forma%20doadora%20de%20%26%23xF3%3Bxido%20n%26%23xED%3Btrico%2C%20nitratos%20org%26%23xE2%3Bnicos%20ou%20nitritos%20org%26%23xE2%3Bnicos%3B%20tanto%20os%20de%20uso%20frequente%20quanto%20os%20de%20uso%20intermitente%20(vide%20item%206.%20Intera%26%23xE7%3B%26%23xF5%3Bes%20Medicamentosas).%3C%2Fp%3E%0A%3Cp%3EA%20coadministra%26%23xE7%3B%26%23xE3%3Bo%20de%20inibidores%20da%20PDE5%2C%20incluindo%20sildenafila%2C%20com%20estimuladores%20da%20guanilato%20ciclase%2C%20tais%20como%20riociguate%2C%20est%26%23xE1%3B%20contraindicada%2C%20uma%20vez%20que%20pode%20potencialmente%20levar%20a%20hipotens%26%23xE3%3Bo%20sintom%26%23xE1%3Btica.%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EEste%20medicamento%20%26%23xE9%3B%20contraindicado%20para%20uso%20por%20pacientes%20em%20tratamento%20com%20medicamentos%20que%20contenham%20qualquer%20forma%20doadora%20de%20%26%23xF3%3Bxido%20n%26%23xED%3Btrico%2C%20nitratos%20org%26%23xE2%3Bnicos%20ou%20nitritos%20org%26%23xE2%3Bnicos.%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EEste%20medicamento%20%26%23xE9%3B%20contraindicado%20para%20uso%20por%20mulheres.%20Este%20medicamento%20%26%23xE9%3B%20contraindicado%20para%20menores%20de%2018%20anos.%3C%2Fstrong%3E%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3E%3Cstrong%3EADVERT%26%23xCA%3BNCIAS%20E%20PRECAU%26%23xC7%3B%26%23xD5%3BES%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3EO%20conhecimento%20da%20hist%26%23xF3%3Bria%20cl%26%23xED%3Bnica%20e%20a%20realiza%26%23xE7%3B%26%23xE3%3Bo%20d%20e%20um%20exame%20f%26%23xED%3Bsico%20completo%20s%26%23xE3%3Bo%20necess%26%23xE1%3Brios%20para%20se%20diagnosticar%20a%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%2C%20determinar%20as%20prov%26%23xE1%3Bveis%20causas%20e%20identificar%20o%20tratamento%20adequado.%3C%2Fp%3E%0A%3Cp%3EExiste%20um%20grau%20de%20risco%20card%26%23xED%3Baco%20associado%20%26%23xE0%3B%20atividade%20sexual.%20Portanto%2C%20os%20m%26%23xE9%3Bdicos%20podem%20considerar%20uma%20avalia%26%23xE7%3B%26%23xE3%3Bo%20da%20condi%26%23xE7%3B%26%23xE3%3Bo%20cardiovascular%20dos%20seus%20pacientes%20antes%20de%20iniciarem%20qualquer%20tratamento%20para%20a%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil.%3C%2Fp%3E%0A%3Cp%3EOs%20agentes%20para%20o%20tratamento%20da%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20n%26%23xE3%3Bo%20devem%20ser%20utilizados%20em%20homens%20para%20os%20quais%20a%20atividade%20sexual%20esteja%20desaconselhada.%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3EForam%20relatados%20eventos%20cardiovasculares%20graves%20p%26%23xF3%3Bs-comercializa%26%23xE7%3B%26%23xE3%3Bo%2C%26%23xA0%3Bincluindo%20infarto%20do%20mioc%26%23xE1%3Brdio%2C%20morte%20s%26%23xFA%3Bbita%20card%26%23xED%3Baca%2C%20arritmia%20ventricular%2C%20hemorragia%20cerebrovascular%20e%20ataque%20isqu%26%23xEA%3Bmico%20transit%26%23xF3%3Brio%20em%20associa%26%23xE7%3B%26%23xE3%3Bo%20temporal%20com%20o%20uso%20do%20citrato%20de%20sildenafila%20para%20a%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil.%20A%20maioria%2C%20mas%20n%26%23xE3%3Bo%20todos%20os%20pacientes%2C%20tinham%20fatores%20de%20risco%20cardiovascular%20pr%26%23xE9%3B-%20existente.%20Foi%20relatado%20que%20muitos%20desses%20eventos%20ocorreram%20durante%20ou%20logo%20ap%26%23xF3%3Bs%20a%20atividade%20sexual%20e%20poucos%20foram%20relatados%20com%20ocorr%26%23xEA%3Bncia%20logo%20a%20p%26%23xF3%3Bs%20o%20uso%20do%20citrato%20de%20sildenafila%20sem%20atividade%20sexual.%3C%2Fp%3E%0A%3Cp%3ERelatou-se%26%23xA0%3Bque%20outros%20ocorreram%20horas%20ou%20dias%20ap%26%23xF3%3Bs%20o%20uso%20do%20citrato%20de%20sildenafila%20e%20atividade%20sexual.%20N%26%23xE3%3Bo%20%26%23xE9%3B%20poss%26%23xED%3Bvel%20determinar%20se%20esses%20eventos%20est%26%23xE3%3Bo%20relacionados%20diretamente%20ao%20uso%20do%20citrato%20de%20sildenafila%2C%20%26%23xE0%3B%20atividade%20sexual%2C%20a%20pacientes%20com%20doen%26%23xE7%3Ba%20cardiovascular%20de%20base%2C%20%26%23xE0%3B%20combina%26%23xE7%3B%26%23xE3%3Bo%20desses%20fatores%20ou%20outros%20fatores.%3C%2Fp%3E%0A%3Cp%3ENos%20estudos%20cl%26%23xED%3Bnicos%2C%20foi%20demonstrado%20que%20a%20sildenafila%20tem%20propriedades%20vasodilatadoras%20sist%26%23xEA%3Bmicas%20que%20resultam%20em%20uma%20diminui%26%23xE7%3B%26%23xE3%3Bo%20transit%26%23xF3%3Bria%20na%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea%20(vide%20item%203%20Caracter%26%23xED%3Bsticas%20Farmacol%26%23xF3%3Bgicas).%20Este%20resultado%20traz%20pouca%20ou%20nenhuma%20consequ%26%23xEA%3Bncia%20para%20a%20maioria%20dos%20pacientes.%20Entretanto%2C%20antes%20da%20sildenafila%20ser%20prescrita%2C%20os%20m%26%23xE9%3Bdicos%20devem%20considerar%20cuidadosamente%20se%20seus%20pacientes%20com%20alguma%20doen%26%23xE7%3Ba%26%23xA0%3Bpr%26%23xE9%3B-existente%26%23xA0%3Bpoderiam%20ser%20afetados%20de%20maneira%20adversa%20por%20esse%20efeito%20vasodilatador%2C%20especialmente%20quando%20em%20combina%26%23xE7%3B%26%23xE3%3Bo%20com%20a%20atividade%20sexual.%20Pacientes%20que%20t%26%23xEA%3Bm%20alta%20susceptibilidade%20a%20vasodilatadores%20incluem%20aqueles%20que%20apresentam%20obstru%26%23xE7%3B%26%23xE3%3Bo%20do%20fluxo%20de%20sa%26%23xED%3Bda%20do%20ventr%26%23xED%3Bculo%20esquerdo%20(por%20ex.%2C%20estenose%20a%26%23xF3%3Brtica%2C%20cardiomiopatia%20hipertr%26%23xF3%3Bfica%20obstrutiva)%20ou%20aqueles%20com%20uma%20s%26%23xED%3Bndrome%20rara%20de%20atrofia%20de%20m%26%23xFA%3Bltiplos%20sistemas%2C%20se%20manifestando%20como%20um%20controle%20aut%26%23xF4%3Bnomo%20da%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea%20gravemente%20comprometida.%3C%2Fp%3E%0A%3Cp%3ENeuropatia%20%26%23xF3%3Bptica%20isqu%26%23xEA%3Bmica%20anterior%20n%26%23xE3%3Bo%20arter%26%23xED%3Btica%20(NAION)%2C%20uma%20condi%26%23xE7%3B%26%23xE3%3Bo%20rara%20e%20uma%20causa%20da%20diminui%26%23xE7%3B%26%23xE3%3Bo%20ou%20perda%20da%20vis%26%23xE3%3Bo%2C%20foi%20raramente%20relatada%20na%26%23xA0%3Bp%26%23xF3%3Bs-comercializa%26%23xE7%3B%26%23xE3%3Bo%26%23xA0%3Bcom%20o%20uso%20de%20todos%20os%20inibidores%20da%20PDE5%2C%20incluindo%20a%20sildenafila.%20A%20maioria%20destes%20pacientes%20apresentava%20fatores%20de%20risco%20como%20baixa%20taxa%20de%20disco%20%26%23xF3%3Bptico%20(%26%23x201C%3Bcrowded%20disc%3Cem%3E%26%23x201D%3B)%3C%2Fem%3E%2C%20idade%20superior%20a%2050%20anos%2C%20diabetes%2C%20hipertens%26%23xE3%3Bo%2C%20doen%26%23xE7%3Ba%20arterial%20coronariana%2C%20hiperlipidemia%20e%20tabagismo.%20Um%20estudo%20observacional%20avaliou%20se%20o%20uso%20recente%20de%20inibidores%20de%20PDE5%2C%20como%20classe%2C%20foi%20associado%20ao%20in%26%23xED%3Bcio%20agudo%20de%20NAION.%20Os%20resultados%20sugerem%20um%20aumento%20aproximado%20de%20duas%20vezes%20no%20risco%20de%20NAION%20dentro%20de%205%26%23xA0%3Bmeia-vidas%26%23xA0%3Bde%20uso%20do%20inibidor%20de%20PDE5.%20Com%20base%20na%20literatura%20publicada%2C%20a%20incid%26%23xEA%3Bncia%20anual%20de%20NAION%20%26%23xE9%3B%20de%26%23xA0%3B2%2C5-11%2C8%26%23xA0%3Bcasos%20por001.000%20homens%20com%20idade%26%23xA0%3B%26%23x2265%3B50%20por%20ano%20na%20popula%26%23xE7%3B%26%23xE3%3Bo%20geral.%20No%20caso%20de%20perda%20repentina%20da%20vis%26%23xE3%3Bo%2C%20os%20pacientes%20devem%20ser%20advertidos%20a%20interromper%20o%20uso%20de%20sildenafila%20e%20consultar%20um%20m%26%23xE9%3Bdico%20imediatamente.%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3EOs%20indiv%26%23xED%3Bduos%20que%20j%26%23xE1%3B%20apresentaram%20NAION%20t%26%23xEA%3Bm%20riscoumentado%20de%20recorr%26%23xEA%3Bncia.%20Portanto%2C%20os%20m%26%23xE9%3Bdicos%20devem%20discutir%20esse%20risco%20com%20esses%20pacientes%20e%20se%20eles%20podem%20ser%20adversamente%20afetados%20pelo%20uso%20de%20inibidores%20de%20PDE5.%20Os%20inibidores%20de%20PDE5%2C%20incluindo%20a%20sildenafila%2C%20devem%20ser%20usados%20com%20cautela%20nesses%20pacientes%20e%20apenas%20quando%20os%20benef%26%23xED%3Bcios%20antecipados%20superarem%20os%20riscos.%3C%2Fp%3E%0A%3Cp%3ERecomenda-se%26%23xA0%3Bcautela%20na%20administra%26%23xE7%3B%26%23xE3%3Bo%20concomitante%20de%20sildenafila%20em%20pacientes%20recebendo%26%23xA0%3B%26%23x3B1%3B-%20bloqueadores%2C%20pois%20a%20coadministra%26%23xE7%3B%26%23xE3%3Bo%20pode%20levar%20%26%23xE0%3B%20hipotens%26%23xE3%3Bo%20sintom%26%23xE1%3Btica%20em%20alguns%20poucos%20indiv%26%23xED%3Bduos%20suscet%26%23xED%3Bveis%20(vide%20item%206.%20Intera%26%23xE7%3B%26%23xF5%3Bes%20Med%20icamentosas).%20A%20fim%20de%20diminuir%20o%20potencial%20de%20desenvolver%20hipotens%26%23xE3%3Bo%20postural%2C%20o%20paciente%20deve%20estar%20est%26%23xE1%3Bvel%20hemodinamicamente%20durante%20a%20terapia%20com%26%23xA0%3B%26%23x3B1%3B-bloqueadores%26%23xA0%3Bantes%20de%20iniciar%20o%20tratamento%20com%20sildenafila.%26%23xA0%3BDeve-se%26%23xA0%3Bconsiderar%20a%20menor%20dose%20de%20sildenafila%20para%20iniciar%20a%20terapia%20(vide%20item%208.%20Posologia%20e%20Modo%20de%20usar).%20Al%26%23xE9%3Bm%20do%20mais%2C%20o%20m%26%23xE9%3Bdico%20deve%20alertar%20o%20que%20o%20paciente%20deve%20fazer%20caso%20ele%20apresente%20sintomas%20de%20hipotens%26%23xE3%3Bo%20postural.%3C%2Fp%3E%0A%3Cp%3EUma%20minoria%20dos%20pacientes%20que%20t%26%23xEA%3Bm%20retinite%20pigmentosa%20heredit%26%23xE1%3Bria%20apresenta%20altera%26%23xE7%3B%26%23xF5%3Bes%20gen%26%23xE9%3Bticas%20das%20fosfodiesterases%20da%20retina.%20N%26%23xE3%3Bo%20existem%20informa%26%23xE7%3B%26%23xF5%3Bes%20relativas%20%26%23xE0%3B%20seguran%26%23xE7%3Ba%20da%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20citrato%20de%20sildenafila%20a%20pacientes%20com%20retinite%20pigmentosa%2C%20portanto%2C%20o%20citrato%20de%20sildenafila%20deve%20ser%20administrado%20com%20precau%26%23xE7%3B%26%23xE3%3Bo%20a%20esses%20pacientes.%3C%2Fp%3E%0A%3Cp%3EEstudos%26%23xA0%3B%3Cem%3Ein%20vitro%26%23xA0%3B%3C%2Fem%3Ecom%20plaquetas%20humanas%20indicam%20que%20a%20sildenafila%20potencializa%20o%20efeito%20antiagregante%20do%20nitroprussiato%20de%20s%26%23xF3%3Bdio%20(um%20doador%20de%20%26%23xF3%3Bxido%20n%26%23xED%3Btrico).%20N%26%23xE3%3Bo%20existem%20informa%26%23xE7%3B%26%23xF5%3Bes%20relativas%20%26%23xE0%3B%20seguran%26%23xE7%3Ba%20da%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20citrato%20de%20sildenafila%20a%20pacientes%20com%20dist%26%23xFA%3Brbios%20hemorr%26%23xE1%3Bgicos%20ou%20com%20%26%23xFA%3Blcera%20p%26%23xE9%3Bptica%20ativa.%20Por%20essemotivo%2C%20o%20citrato%20de%20sildenafila%20deve%20ser%20administrado%20com%20precau%26%23xE7%3B%26%23xE3%3Bo%20a%20esses%20pacientes.%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3EOs%20agentes%20para%20tratamento%20da%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20devem%20ser%20utilizados%20com%20precau%26%23xE7%3B%26%23xE3%3Bo%20em%20pacientes%20com%20deforma%26%23xE7%3B%26%23xF5%3Bes%20anat%26%23xF4%3Bmicas%20do%20p%26%23xEA%3Bnis%20(tais%20como%20angu%20la%26%23xE7%3B%26%23xE3%3Bo%2C%20fibrose%20cavernosa%20ou%20doen%26%23xE7%3Ba%20de%20Peyronie)%20ou%20em%20pacientes%20com%20condi%26%23xE7%3B%26%23xF5%3Bes%20que%20possam%26%23xA0%3Bpredisp%26%23xF4%3B-los%26%23xA0%3Bao%20priapismo%20(tais%20como%20anemia%20falciforme%2C%20mieloma%20m%26%23xFA%3Bltiplo%20ou%20leucemia).%3C%2Fp%3E%0A%3Cp%3EEre%26%23xE7%3B%26%23xF5%3Bes%20prolongadas%20e%20priapismo%20foram%20relatados%20com%20sildenafila%20em%20experi%26%23xEA%3Bncias%20p%26%23xF3%3Bs-%20comercializa%26%23xE7%3B%26%23xE3%3Bo.%20Em%20caso%20de%20persist%26%23xEA%3Bncia%20de%20ere%26%23xE7%3B%26%23xE3%3Bo%20por%20mais%20do%20que%204%20horas%2C%20o%20paciente%20deve%20procurar%20atendimento%20m%26%23xE9%3Bdico%20imediatamente.%20Se%20n%26%23xE3%3Bo%20for%20tratado%20imediatamente%2C%20o%20priapismo%20pode%20resultar%20em%20danos%20teciduais%20e%20impot%26%23xEA%3Bncia%20permanente.%3C%2Fp%3E%0A%3Cp%3EA%20seguran%26%23xE7%3Ba%20e%20a%20efic%26%23xE1%3Bcia%20das%20associa%26%23xE7%3B%26%23xF5%3Bes%20de%20citrato%20de%20sildenafila%20com%20outros%20inibidores%20de%20PDE5%2C%20ou%20outros%20tratamentos%20para%20hipertens%26%23xE3%3Bo%20arterial%20pulmonar%20(HAP)%20que%20contenham%20sildenafila%2C%20ou%20outros%20tratamentos%20para%20disfun%26%23xE7%3B%26%23xE3%3Bo%20er%26%23xE9%3Btil%20n%26%23xE3%3Bo%20foram%20estudadas.%20Portanto%2C%20o%20uso%20dessas%20associa%26%23xE7%3B%26%23xF5%3Bes%20n%26%23xE3%3Bo%20%26%23xE9%3B%20recomendado.%3C%2Fp%3E%0A%3Cp%3EDiminui%26%23xE7%3B%26%23xE3%3Bo%20repentina%20ou%20perda%20de%20audi%26%23xE7%3B%26%23xE3%3Bo%20foram%20relatadas%20em%20pequeno%20n%26%23xFA%3Bmero%20de%20pacientes%20na%20p%26%23xF3%3Bs-comercializa%26%23xE7%3B%26%23xE3%3Bo%20e%20em%20estudos%20cl%26%23xED%3Bnicos%20com%20o%20uso%26%23xA0%3B%26%23xA0%3B%20de%20todos%20os%20inibidores%20da%20PDE5%2C%20incluindo%20a%20sildenafila.%20A%20maioria%20destes%20pacientes%20apresentava%20fatores%20de%20risco%20para%20diminui%26%23xE7%3B%26%23xE3%3Bo%20repentina%20ou%20perda%20de%20audi%26%23xE7%3B%26%23xE3%3Bo.%20N%26%23xE3%3Bo%20foi%20identificada%20rela%26%23xE7%3B%26%23xE3%3Bo%20causal%20entre%20o%20uso%20de%20inibidores%20de%20PDE5%20e%20diminui%26%23xE7%3B%26%23xE3%3Bo%20repentina%20ou%20perda%20de%20audi%26%23xE7%3B%26%23xE3%3Bo.%20Em%20caso%20de%20diminui%26%23xE7%3B%26%23xE3%3Bo%20repentina%20ou%20perda%20de%20audi%26%23xE7%3B%26%23xE3%3Bo%2C%20os%20pacientes%20devem%20ser%20advertidos%20a%20interromper%20o%20uso%20de%20sildenafila%20e%20a%20consultarem%20imediatamente%20um%20m%26%23xE9%3Bdico.%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3E%3Cstrong%3EFertilidade%2C%20gravidez%20e%20lacta%26%23xE7%3B%26%23xE3%3Bo%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3EEste%20medicamento%20n%26%23xE3%3Bo%20est%26%23xE1%3B%20indicado%20para%20o%20uso%20em%20mulheres.%3C%2Fp%3E%0A%3Cp%3EN%26%23xE3%3Bo%20foi%20encontrado%20efeito%20teratog%26%23xEA%3Bnico%2C%20diminui%26%23xE7%3B%26%23xE3%3Bo%20da%20fertilidade%20ou%20eventos%20adversos%20no%20desenvolvimento%26%23xA0%3Bperi%2Fp%26%23xF3%3Bs-natal%26%23xA0%3Bem%20ratos%20e%20coelhos%20a%20p%26%23xF3%3Bs%20administra%26%23xE7%3B%26%23xE3%3Bo%20oral%20de%20sildenafila.%3C%2Fp%3E%0A%3Cp%3EN%26%23xE3%3Bo%20existem%20estudos%20adequados%20e%20bem%20controlados%20da%20sildenafila%20em%20mulheres%20gr%26%23xE1%3Bvidas%20e%20lactantes.%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3E%3Cstrong%3EEfeitos%20na%20habilidade%20de%20dirigir%20e%20de%20operar%20m%26%23xE1%3Bquinas%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3EComo%20tonturas%20e%20altera%26%23xE7%3B%26%23xF5%3Bes%20na%20vis%26%23xE3%3Bo%20foram%20relatadas%20em%20ensaios%20cl%26%23xED%3Bnicos%20com%20sildenafila%2C%20os%20pacientes%20devem%20estar%20cientes%20de%20como%20reagem%20%26%23xE0%3B%20sildenafila%2C%20antes%20de%20dirigir%20ou%20operar%20m%26%23xE1%3Bquinas%3Cstrong%3E.%26%23xA0%3B%3C%2Fstrong%3EN%26%23xE3%3Bo%20foi%20estudado%20o%20efeito%20de%20citrato%20de%20sildenafila%20sobre%20a%20habilidade%20de%20dirigir%20ou%20operar%20m%26%23xE1%3Bquinas.%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3E%20INTERA%26%23xC7%3B%26%23xD5%3BES%20MEDICAMENTOSAS%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EEfeitos%20de%20outros%20medicamentos%20sobre%20a%20sildenafila%20Estudos%26%23xA0%3B%3Cem%3Ein%20vitro%3C%2Fem%3E%3C%2Fstrong%3E%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3EO%20metabolismo%20da%20sildenafila%20%26%23xE9%3B%20mediado%20principalmente%20pelas%20isoformas%20do%20citocromo%20P450%20(CYP)%2C%203A4%20(via%20principal)%20e%202C9%20(via%20secund%26%23xE1%3Bria).Portanto%2C%20inibidores%20dessas%20isoenzimas%20podem%20reduzir%20o%20clearance%20da%20sildenafila%20e%20os%20indutores%20podem%26%23xA0%3Baument%26%23xE1%3B-lo.%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EEstudos%26%23xA0%3B%3Cem%3Ein%20vivo%3C%2Fem%3E%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3EOs%20dados%20farmacocin%26%23xE9%3Bticos%20populacionais%20de%20pacientes%20em%20estudos%20cl%26%23xED%3Bnicos%20indicaram%20uma%20diminui%26%23xE7%3B%26%23xE3%3Bo%20do%20clearance%20da%20sildenafila%20quando%20coadm%20inistrada%20com%20inibidores%20do%20citocromo%20CYP3A4%20(tais%20como%20o%20cetoconazol%2C%20eritromicina%20ou%20cimetidina).%3C%2Fp%3E%0A%3Cp%3EA%20cimetidina%20(800mg)%2C%20um%20inibidor%20do%20citocromo%20P450%20e%20um%20inibidor%20CYP3A4%26%23xA0%3Bn%26%23xE3%3Bo-espec%26%23xED%3Bfico%2C%20causou%20um%20aumento%20de%2056%25%20na%20concentra%26%23xE7%3B%26%23xE3%3Bo%20plasm%26%23xE1%3Btica%20da%20sildenafila%2C%20quando%20coadministrada%20com%20citrato%20de%20sildenafila%2050mg%20a%20volunt%26%23xE1%3Brios%20sadio.%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3EQuando%20uma%20dose%20%26%23xFA%3Bnica%20de%20100mg%20de%20citrato%20de%20sildenafila%20foi%20administrada%20com%20eritromicina%2C%20um%20inibidor%20moderado%20do%20CYP3A4%2C%20no%20estado%20de%20equil%26%23xED%3Bbrio%20(500mg%2C%202%20vezes%20por%20dia%20por%205%20dias)%20houve%20um%20aumento%20de%20182%25%20na%20exposi%26%23xE7%3B%26%23xE3%3Bo%20sist%26%23xEA%3Bmica%20%26%23xE0%3B%20s%20ildenafila%20(AUC).%20Al%26%23xE9%3Bm%20disso%2C%20a%20coadministra%26%23xE7%3B%26%23xE3%3Bo%20de%20sildenafila%20(100mg%20em%20dose%20%26%23xFA%3Bnica%20)%20e%20saquinavir%20(um%20inibidor%20da%20protease%20HIV)%2C%20que%20tamb%26%23xE9%3Bm%20%26%23xE9%3B%20um%20inibidor%20do%20CYP3A4%2C%20no%20estado%20de%20equil%26%23xED%3Bbrio%20(1200mg%2C%203%20vezes%20por%20dia)%2C%20resultou%20em%20um%20aumento%20de%20140%25%20na%20Cm%26%23xE1%3Bxe%20de%20210%25%20na%20AUC%20da%20sildenafila.%20A%20sildenafila%20n%26%23xE3%3Bo%20afetou%20a%20farmacocin%26%23xE9%3Btica%20do%20saquinavir%20(vide%20item%208.%20Posologia%20e%20Modo%20de%20usar).%26%23xA0%3BEspera-se%20que%20inibidores%20mais%20potentes%20do%20CYP3A4%2C%20tais%20como%20o%20cetoconazol%20e%20o%20itraconazol%2C%20apresentem%20efeitos%20maiores.%3C%2Fp%3E%0A%3Cp%3EA%20coadministra%26%23xE7%3B%26%23xE3%3Bo%20de%20sildenafila%20(100mg%20em%20dose%20%26%23xFA%3Bnica)%20e%20ritonavir%20(um%20inibidor%20da%20protease%20HIV)%2C%20que%20tamb%26%23xE9%3Bm%20%26%23xE9%3B%20um%20potente%20inibidor%20do%20citocromoP450%2C%20no%20estado%20de%20equil%26%23xED%3Bbrio%20(500mg%2C%202%20vezes%20por%20dia)%2C%20resultou%20em%20um%20aumento%20de%20300%25%20(4%20vezes)%20na%20Cm%26%23xE1%3Bx%20na%20sildenafila%20e%20de%201000%25%20(11%20vezes)%20na%20AUC%20plasm%26%23xE1%3Btica%20da%20sildenafila.%20Ap%26%23xF3%3Bs%2024%20horas%2C%20os%20n%26%23xED%3Bveis%20de%20sildenafila%20no%20plasma%20ainda%20eram%20de%20aproximadamente%20200ng%2FmL%2C%20comparados%20a%20aproximadamente%205ng%2FmL%20quando%20a%20sildenafila%20foi%20administrada%20sozinha.%20Este%20dado%20%26%23xE9%3B%20consistente%20com%20os%20efeitos%20marcantes%20do%20ritonavir%20em%20um%20espectro%20variado%20de%20substratos%20do%20citocromo%20P450.%20A%20sildenafila%20n%26%23xE3%3Bo%20apresentou%20qualquer%20efeito%20sobre%20a%20farmacocin%26%23xE9%3Btica%20do%20ritonavi%20(vide%20item%208.%20Posologia%20e%20Modo%20de%20usar).%3C%2Fp%3E%0A%3Cp%3EQuando%20a%20dose%20de%20sildenafila%20foi%20administrada%2C%20conforme%20recomenda%26%23xE7%3B%26%23xE3%3Bo%2C%20em%20pacientes%20recebendo%20inibidores%20potentes%20do%20citocromo%20CYP3A4%2C%20a%20concentra%26%23xE7%3B%26%23xE3%3Bo%20plasm%26%23xE1%3Btica%20m%26%23xE1%3Bxima%20de%20sildenafila%20livre%20n%26%23xE3%3Bo%20foi%20superior%20a%20200nM%20em%20todos%20os%20indiv%26%23xED%3Bduos%20avaliados%2C%20e%20foram%20consistentemente%20bem%20toleradas.%3C%2Fp%3E%0A%3Cp%3EDoses%20%26%23xFA%3Bnicas%20de%20anti%26%23xE1%3Bcidos%20(hidr%26%23xF3%3Bxido%20de%20magn%26%23xE9%3Bsio%2Fhidr%26%23xF3%3Bxido%20de%20alum%26%23xED%3Bnio)%20n%26%23xE3%3Bo%20afetam%20a%20biodisponibilidade%20de%20citrato%20de%20sildenafila.%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3EEm%20um%20estudo%20com%20volunt%26%23xE1%3Brios%20saud%26%23xE1%3Bveis%20do%20sexo%20masculino%2C%20a%20coadministra%26%23xE7%3B%26%23xE3%3Bo%20do%20antagonista%20de%20endotelina%2C%20bosentana%20(um%20indutor%20do%20CYP3A4%20%5Bmoderado%5D%2C%20CYP2C9%20e%20possivelmente%20do%20CYP2C19)%20no%20estado%20de%20equil%26%23xED%3Bbrio%20(125mg%2C%20duas%20vezes%20por%20dia)%20com%20sildenafila%20no%20estado%20de%20equil%26%23xED%3Bbrio%20(80mg%2C%20tr%26%23xEA%3Bs%20vezes%20por%20dia)%20resultou%20em%20uma%20redu%26%23xE7%3B%26%23xE3%3Bo%20de%2062%2C6%25%20e%2055%2C4%25%20na%20AUC%20e%20na%20Cmax%26%23xA0%3Bda%20sildenafila%2C%20respectivamente.%20A%20sildenafila%20aumentou%20a%20AUC%20e%20a%20Cmax%26%23xA0%3Bdo%20bosentana%20em%2049%2C8%25%20e%2042%25%2C%20respectivamente.%26%23xA0%3BEspera-se%26%23xA0%3Bque%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20concomitante%20de%20indutores%20potentes%20do%20CYP3A4%2C%20como%20a%20rifampicina%2C%20cause%20redu%26%23xE7%3B%26%23xF5%3Bes%20ainda%20maiores%20nas%20concentra%26%23xE7%3B%26%23xF5%3Bes%20plasm%26%23xE1%3Bticas%20da%20sildenafila.%3C%2Fp%3E%0A%3Cp%3EOs%20dados%20farmacocin%26%23xE9%3Bticos%20dos%20pacientes%20inclu%26%23xED%3Bdos%20em%20estudos%20cl%26%23xED%3Bnicos%20n%26%23xE3%3Bo%20demonstraram%20qualquer%20efeito%20da%20medica%26%23xE7%3B%26%23xE3%3Bo%20concomitante%20sobre%20a%20farmacocin%26%23xE9%3Btica%20da%20sildenafila%2C%20quando%20essas%20medica%26%23xE7%3B%26%23xF5%3Bes%20foram%20agrupadas%20da%20seguinte%20forma%3A%20inibi%20dores%20do%20citocromo%20CYP2C9%20(tais%20como%20tolbutamida%2C%20varfarina)%2C%20inibidores%20do%20citocromo%20CYP2D6%20(tais%20como%20os%20inibidores%20seletivos%20da%20recapta%26%23xE7%3B%26%23xE3%3Bo%20de%20serotonina%2C%20antidepressivos%20tric%26%23xED%3Bclicos)%2C%20tiazidas%20e%20diur%26%23xE9%3Bticos%20relacionados%2C%20inibidores%20da%20enzima%20conversora%20de%20angiotensina%20(IECA)%20e%20bloqueadores%20de%20canais%20de%20c%26%23xE1%3Blcio.%20A%20AUC%20do%20metab%26%23xF3%3Blito%20ativo%2C%26%23xA0%3BN-desmetil%26%23xA0%3Bsildenafila%2C%20estava%20aumentada%20em%2062%25%20por%20diur%26%23xE9%3Bticos%20de%20al%26%23xE7%3Ba%20e%20poupadores%20de%20pot%26%23xE1%3Bssio%20e%20102%25%20pelos%20betabloqueadores%20n%26%23xE3%3Bo%20espec%26%23xED%3Bficos.%20N%26%23xE3%3Bo%20se%20espera%20que%20estes%20efeitos%20sobre%20o%20metab%26%23xF3%3Blito%20tenham%20consequ%26%23xEA%3Bncias%20cl%26%23xED%3Bnicas.%3C%2Fp%3E%0A%3Cp%3EEm%20volunt%26%23xE1%3Brios%20sadios%20do%20sexo%20masculino%20n%26%23xE3%3Bo%20existiram%20evid%26%23xEA%3Bncias%20sobre%20o%20efeito%20da%20azitromicina%20(500mg%20di%26%23xE1%3Brios%2C%20por%203%20dias)%20na%20AUC%2C%20Cm%26%23xE1%3Bx%2C%20Tm%26%23xE1%3Bx%2C%20constante%20da%20taxa%20de%20elimina%26%23xE7%3B%26%23xE3%3Bo%20ou%20na%26%23xA0%3Bmeia-vida%26%23xA0%3Bda%20sildenafila%20ou%20de%20seu%20principal%20metab%26%23xF3%3Blito%20circulante.%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EEfeitos%20do%20citrato%20de%20sildenafila%20sobre%20outros%20medicamentos%3C%2Fstrong%3E%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3E%3Cstrong%3EEstudos%26%23xA0%3B%3Cem%3Ein%20vitro%3C%2Fem%3E%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3EA%20sildenafila%20%26%23xE9%3B%20um%20fraco%20inibidor%20isoformas%20do%20citocromo%20P450%2C%20isoformas%201A2%2C%202C9%2C%202C19%2C%202D6%2C%202E1%20e%203A4%20(IC50%20%26gt%3B150%26%23xB5%3BM).%20Uma%20vez%20que%20o%20pico%20de%20concentra%26%23xE7%3B%26%23xE3%3Bo%20plasm%26%23xE1%3Btica%20da%20sildenafila%20%26%23xE9%3B%20de%20aproximadamente%201%26%23xB5%3BM%20ap%26%23xF3%3Bs%20as%20doses%20recomendadas%2C%20%26%23xE9%3B%20improv%26%23xE1%3Bvel%20que%20citrato%20de%20sildenafila%20altere%20o%20clearance%20dos%20substratos%20dessas%20isoenzimas.%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3E%3Cem%3EEstudos%20in%20vivo%3C%2Fem%3E%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3EFoi%20demonstrado%20que%20o%20citrato%20de%20sildenafila%20potencializa%20o%20efeito%20hipotensor%20da%20terap%26%23xEA%3Butica%20com%20nitratos%2C%20tanto%20de%20uso%20agudo%20quanto%20cr%26%23xF4%3Bnico.%20Portanto%2C%20o%20uso%20de%20qualquer%20forma%20doadora%20de%20%26%23xF3%3Bxido%20n%26%23xED%3Btrico%2C%20nitratos%20ou%20nitritos%20org%26%23xE2%3Bnicos%2C%20de%20uso%20regular%20ou%20intermitente%20com%20citrato%20de%20sildenafila%2C%20%26%23xE9%3B%20contraindicado%20(vide%20item%204.Contraindica%26%23xE7%3B%26%23xF5%3Bes).%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3EEm%203%20estudos%20espec%26%23xED%3Bficos%20de%20intera%26%23xE7%3B%26%23xE3%3Bo%26%23xA0%3Bf%26%23xE1%3Brmaco-f%26%23xE1%3Brmaco%2C%26%23xA0%3Bo%26%23xA0%3B%26%23x3B1%3B-bloqueador%26%23xA0%3Bdoxazosina%20(4mg%20e%208mg)%20e%20a%20sildenafila%20(25mg%2C%2050mg%20ou%20100mg)%20foram%20administrados%20simultaneamente%20a%20pacientes%20com%20hiperplasia%20prost%26%23xE1%3Btica%20benigna%20(HPB)%20est%26%23xE1%3Bvel%20em%20tratamento%20com%20doxazosina.%20Foi%20observado%2C%20nesta%20popula%26%23xE7%3B%26%23xE3%3Bo%20de%20estudo%2C%20que%20as%20redu%26%23xE7%3B%26%23xF5%3Bes%20adicionais%20m%26%23xE9%3Bdias%20da%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea%20na%20posi%26%23xE7%3B%26%23xE3%3Bo%20supina%20foi%20de%207%2F7mmHg%2C%209%2F5mmHg%20e%208%2F4mmHg%2C%20e%20as%20redu%26%23xE7%3B%26%23xF5%3Bes%20adicionais%20m%26%23xE9%3Bdias%20da%20press%26%23xE3%3Bo%20sangu%26%23xED%3Bnea%20em%20p%26%23xE9%3B%20foi%20de%206%2F6mmHg%2C%2011%2F4mmHg%20e%204%2F5mmHg%2Crespectivamente.%3C%2Fp%3E%0A%3Cp%3EQuando%20a%20sildenafila%20%26%23xE9%3B%20coadministrada%20com%20doxazosina%20em%20pacientes%20est%26%23xE1%3Bveis%20em%20terapia%20com%20doxazosina%2C%20houve%20relatos%20infrequentes%20de%20pacientes%20que%20apresentaram%20hipotens%26%23xE3%3Bo%20postural%20sintom%26%23xE1%3Btica.%20Estes%20relatos%20inclu%26%23xED%3Bram%20tontura%20e%20sensa%26%23xE7%3B%26%23xE3%3Bo%20de%20cabe%26%23xE7%3Ba%20vazia%2C%20mas%20sem%20desmaio.%20A%20coadministra%26%23xE7%3B%26%23xE3%3Bo%20de%20sildenafila%20a%20pacientes%20em%20terapia%20com%26%23xA0%3B%26%23x3B1%3B-bloqueadores%26%23xA0%3Bpode%20levar%20%26%23xE0%3B%20hipotens%26%23xE3%3Bo%20sintom%26%23xE1%3Btica%20em%20alguns%20poucos%20indiv%26%23xED%3Bduos%20suscet%26%23xED%3Bveis%20(vide%20itens%205.%20Advert%26%23xEA%3Bncias%20e%20Precau%26%23xE7%3B%26%23xF5%3Bes%20e%208.%20Posologia%20e%20Modo%20de%20usar).%3C%2Fp%3E%0A%3Cp%3EN%26%23xE3%3Bo%20foi%20demonstrada%20intera%26%23xE7%3B%26%23xE3%3Bo%20significativa%20quando%20a%20sildenafila%20(50mg)%20foi%20coadministrada%20com%20a%20tolbutamida%20(250mg)%20ou%20varfarina%20(40mg)%2C%20sendo%20que%20ambas%20s%26%23xE3%3Bo%20metabolizadas%20pelo%20citocromo%20CYP2C9.%3C%2Fp%3E%0A%3Cp%3EO%20citrato%20de%20sildenafila%20(100mg)%20n%26%23xE3%3Bo%20afetou%20a%20farmacocin%26%23xE9%3Btica%20do%20estado%20de%20equil%26%23xED%3Bbrio%20dos%20inibidores%20da%20protease%20HIV%2C%20saquinavir%20e%20ritonavir%2C%20ambos%20substratos%20do%20citocromo%20CYP3A4.%20(Vide%20item%206.%20Intera%26%23xE7%3B%26%23xF5%3Bes%20Medicamentosas%20%26%23x2013%3B%20Efeitos%20d%20e%20outros%20medicamentos%20sobre%20a%20sildenafila).%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3EO%20citrato%20de%20sildenafila%20em%20estado%20de%20equil%26%23xED%3Bbrio%20(80mg%2C%20tr%26%23xEA%3Bs%20vezes%20ao%20dia)%20resultou%20em%20um%20aumento%20de%2049%2C8%25%20na%20AUC%20do%20bosentana%20e%20um%20aumento%20de%2042%25%20na%20Cmax%26%23xA0%3Bdo%20bosentana%20(125mg%2C%20duas%20vezes%20ao%20dia)%20(vide%20item%206.%20Intera%26%23xE7%3B%26%23xF5%3Bes%20Medicamentosas%20%26%23x2013%3B%20E%20feitos%20de%20outros%20medicamentos%20sobre%20a%20sildenafila).%3C%2Fp%3E%0A%3Cp%3EO%20citrato%20de%20sildenafila%20(50mg)%20n%26%23xE3%3Bo%20potencializou%20o%20aumento%20no%20tempo%20de%20sangramento%20provocado%20pelo%20%26%23xE1%3Bcido%20acetilsalic%26%23xED%3Blico%20(150mg).%3C%2Fp%3E%0A%3Cp%3EO%20citrato%20de%20sildenafila%20(50%20mg)%20n%26%23xE3%3Bo%20potencializou%20os%20efeitos%20hipotensores%20do%20%26%23xE1%3Blcool%20em%20volunt%26%23xE1%3Brios%20sadios%20com%20n%26%23xED%3Bveis%20m%26%23xE9%3Bdios%20m%26%23xE1%3Bximos%20de%20%26%23xE1%3Blcool%20no%20sangue%20de%200%2C08%25%20(80%20mg%2FdL).%3C%2Fp%3E%0A%3Cp%3EN%26%23xE3%3Bo%20foi%20observada%20intera%26%23xE7%3B%26%23xE3%3Bo%20quando%20a%20sildenafila%20(1%2000mg)%20foi%20coadministrada%20com%20anlodipino%20em%20pacientes%20hipertensos.%20A%20m%26%23xE9%3Bdia%20da%20redu%26%23xE7%3B%26%23xE3%3Bo%20adicional%20da%20press%26%23xE3%3Bo%20arterial%20na%20posi%26%23xE7%3B%26%23xE3%3Bo%20supina%20foi%20de%208mmHg%20(sist%26%23xF3%3Blica)%20e%207mmHg%20(diast%26%23xF3%3Blica).%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3EA%20an%26%23xE1%3Blise%20de%20dados%20sobre%20seguran%26%23xE7%3Ba%20n%26%23xE3%3Bo%20demonstrou%20qualquer%20diferen%26%23xE7%3Ba%20no%20perfil%20de%20efeitos%20colaterais%20em%20pacientes%20tratados%20com%20citrato%20de%20sildenafila%2C%20na%20presen%26%23xE7%3Ba%20e%20aus%26%23xEA%3Bncia%20de%20medica%26%23xE7%3B%26%23xE3%3Bo%26%23xA0%3Banti-hipertensiva.%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3E%20CUIDADOS%20DE%20ARMAZENAMENTO%20DO%20MEDICAMENTO%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3ECONSERVAR%20EM%20TEMPERATURA%20AMBIENTE%20(15%20A%2030%26%23xB0%3BC).%20PROT%20EGER%20DA%20LUZ%20E%20UMIDADE.%3C%2Fp%3E%0A%3Cp%3EEste%20medicamento%20tem%20prazo%20de%20validade%20de%2024%20meses%20a%20partir%20da%20data%20de%20sua%20fabrica%26%23xE7%3B%26%23xE3%3Bo.%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3E%3Cstrong%3EN%26%23xFA%3Bmero%20de%20lote%20e%20datas%20de%20fabrica%26%23xE7%3B%26%23xE3%3Bo%20e%20validade%3A%20vi%20de%20embalagem.%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EN%26%23xE3%3Bo%20use%20medicamento%20com%20o%20prazo%20de%20validade%20vencido%20.%26%23xA0%3BGuarde-o%26%23xA0%3Bem%20sua%20embalagem%20original.%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3E%26%23xA0%3B%3C%2Fstrong%3E%3Cstrong%3ECaracter%26%23xED%3Bsticas%20f%26%23xED%3Bsicas%20e%20organol%26%23xE9%3Bpticas%3A%26%23xA0%3B%3C%2Fstrong%3EComprimido%20revestido%20azul%2C%20em%20formato%20redondo%20e%20biconvexo.%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EAntes%20de%20usar%2C%20observe%20o%20aspecto%20do%20medicamento.%3C%2Fstrong%3E%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3E%3Cstrong%3ETodo%20medicamento%20deve%20ser%20mantido%20fora%20do%20alcance%20das%20crian%26%23xE7%3Bas.%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3E%20POSOLOGIA%20E%20MODO%20DE%20USAR%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3EOs%20comprimidos%20de%20citrato%20de%20sildenafila%26%23xA0%3Bdestinam-se%26%23xA0%3B%26%23xE0%3B%20administra%26%23xE7%3B%26%23xE3%3Bo%20por%20via%20oral.%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EUso%20em%20adultos%3C%2Fstrong%3E%3A%20Para%20a%20maioria%20dos%20pacientes%2C%20a%20dose%20recomendada%20%26%23xE9%3B%20de%2050mg%20em%20dose%20%26%23xFA%3Bnica%2C%20administrada%2C%20quando%20necess%26%23xE1%3Bria%20aproximadamente%201%20hora%20antes%20da%20rela%26%23xE7%3B%26%23xE3%3Bo%20sexual.%20De%20acordo%20com%20a%20efic%26%23xE1%3Bcia%20e%20tolerabilidade%2C%20a%20dose%20pode%20ser%20aumentada%20para%20uma%20dose%20m%26%23xE1%3Bxima%20recomendada%20de%20100mg%20ou%20diminu%26%23xED%3Bda%20para%2025mg.%20A%20dose%20m%26%23xE1%3Bxima%20recomendada%20%26%23xE9%3B%20de%20100mg.%20A%20frequ%26%23xEA%3Bncia%20m%26%23xE1%3Bxima%20recomendada%20de%20citrato%20de%20sildenafila%26%23xE9%3B%20de%201%20vez%20ao%20dia.%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3E%3Cstrong%3EUso%20em%20pacientes%20com%20insufici%26%23xEA%3Bncia%20renal%3A%20%3C%2Fstrong%3EN%26%23xE3%3Bo%20%26%23xE9%3B%20necess%26%23xE1%3Brio%20ajuste%20de%20dose%20em%20pacientes%20com%20insufici%26%23xEA%3Bncia%20renal%20leve%20a%20moderada%20(clearance%20de%20reatininac%20%3D%2030%20%26%23x2013%3B%2080mL%2Fmin).%20Uma%20vez%20que%20o%20clearance%20da%20sildenafila%20%26%23xE9%3B%20reduzido%20em%20pacientes%20com%20insufici%26%23xEA%3Bncia%20renal%20grave%20(clearance%20de%20creatinina%20%26lt%3B%2030mL%2Fmin)%2C%20uma%20dose%20de%2025mg%20deve%20ser%20considerada.%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EUso%20em%20pacientes%20com%20insufici%26%23xEA%3Bncia%20hep%26%23xE1%3Btica%3A%20%3C%2Fstrong%3EUma%20vez%20que%20o%20clearance%20da%20sildenafila%20%26%23xE9%3B%20reduzido%20em%20pacientes%20com%20insufici%26%23xEA%3Bncia%20hep%26%23xE1%3Btica%20lasse(c%20A%20ou%20B%20de%26%23xA0%3BChild-Pugh)%26%23xA0%3B(por%20ex.%3A%20cirrose)%2C%20uma%20dose%20de%2025mg%20deve%20ser%20considerada.%20A%20farmacocin%26%23xE9%3Btica%20da%20sildenafila%20em%20pacientes%20com%20insufici%26%23xEA%3Bncia%20hep%26%23xE1%3Btica%20grave%20(classe%20C%20de%26%23xA0%3BChild-Pugh)%26%23xA0%3Bn%26%23xE3%3Bo%20foi%20estudada.%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EUso%20em%20pacientes%20que%20utilizam%20outras%20medica%26%23xE7%3B%26%23xF5%3Bes%3A%26%23xA0%3BConsiderando%20a%20extens%26%23xE3%3Bo%20da%20intera%26%23xE7%3B%26%23xE3%3Bo%20em%20pacientes%20em%20tratamento%20concomitante%20com%20sildenafila%20e%20ritonavir%20(vide%20item%206.%20Intera%26%23xE7%3B%26%23xF5%3Bes%20Medicamentosas)%2C%26%23xA0%3Brecomenda-se%26%23xA0%3Bn%26%23xE3%3Bo%20exceder%20a%20dose%20%26%23xFA%3Bnica%20m%26%23xE1%3Bxima%20de%2025mg%20de%20sildenafila%20em%20um%20per%26%23xED%3Bodo%20de%2048%20horas.%20Uma%20dose%20inicial%20de%2025mg%20deve%20ser%20considerada%20em%20pacientes%20recebendo%20terapia%20concomitante%20com%20inibidores%20da%20CYP3A4%20(por%20ex.%3A%20eritromicina%2C%20saquinavir%2C%20cetoconazol%2C%20itraconazol)%20(vide%20item%206.%20Intera%26%23xE7%3B%26%23xF5%3Bes%20Medicamentosas).%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3EA%20fim%20de%20diminuir%20o%20potencial%20de%20desenvolver%20hipotens%26%23xE3%3Bo%20postural%2C%20o%20paciente%20deve%20estar%20est%26%23xE1%3Bvel%20durante%20a%20terapia%20com%26%23xA0%3B%26%23x3B1%3B-bloqueadores%26%23xA0%3Bantes%20de%20iniciar%20o%20tratamento%20com%20sildenafila.%20Al%26%23xE9%3Bm%20disso%2C%26%23xA0%3Bdeve-se%26%23xA0%3Bconsiderar%20a%20menor%20dose%20de%20sildenafila%20para%20iniciar%20a%20terapia%20(vide%20itens%205.%20Advert%26%23xEA%3Bncias%20e%20Precau%26%23xE7%3B%26%23xF5%3Bes%20e%206.%20Intera%26%23xE7%3B%26%23xF5%3Bes%20Medicamentosas).%20Foi%20demonstrado%20que%20citrato%20de%20sildenafila%20potencializa%20o%20efeito%20hipotensor%20dos%20nitratos.%20Portanto%2C%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20a%20pacientes%20que%20fazem%20uso%20de%20medicamentos%20doadores%20de%20%26%23xF3%3Bxido%20n%26%23xED%3Btrico%20ou%20nitratos%20sob%20qualquer%20forma%2C%20%26%23xE9%3B%20contraindicada.%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3E%3Cstrong%3EUso%20em%20crian%26%23xE7%3Bas%3C%2Fstrong%3E%3A%20O%20citrato%20de%20sildenafila%20n%26%23xE3%3Bo%20%26%23xE9%3B%20indicado%20para%20o%20uso%20em%20crian%26%23xE7%3Bas%20(%26lt%3B%2018%20anos).%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EUso%20em%20idosos%3A%26%23xA0%3B%3C%2Fstrong%3EO%20ajuste%20de%20dose%20n%26%23xE3%3Bo%20%26%23xE9%3B%20necess%26%23xE1%3Brio%20para%20pacientes%20idosos.%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EEste%20medicamento%20n%26%23xE3%3Bo%20deve%20ser%20partido%2C%20aberto%20ou%20mastigado.%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EREA%26%23xC7%3B%26%23xD5%3BES%20ADVERSAS%3C%2Fstrong%3E%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3EOs%20eventos%20adversos%20foram%2C%20em%20geral%2C%20transit%26%23xF3%3Brios%20e%20de%20natureza%20leve%20a%20moderada.%3C%2Fp%3E%0A%3Cp%3EEm%20estudos%20de%20dose%20fixa%2C%20a%20incid%26%23xEA%3Bncia%20de%20alguns%20eventos%20adversos%20aumentou%20com%20a%20dose.%20A%20natureza%20dos%20eventos%20adversos%20em%20estudos%20de%20dose%20flex%26%23xED%3Bvel%2C%20que%20refletem%20de%20forma%20mais%20adequada%20o%20regime%20posol%26%23xF3%3Bgico%20recomendado%2C%20foi%20semelhante%20%26%23xE0%3Bqu%20ela%20observada%20nos%20estudos%20de%20dose%20fixa.%3C%2Fp%3E%0A%3Cp%3EAs%20rea%26%23xE7%3B%26%23xF5%3Bes%20adversas%20mais%20comumente%20relatadas%20foram%20cefaleia%20e%20rubor.%3C%2Fp%3E%0A%3Cp%3ERea%26%23xE7%3B%26%23xF5%3Bes%20adversas%20por%20Classe%20de%20Sistema%20de%20%26%23xD3%3Brg%26%23xE3%3Bos%20(S%20OC)%20e%20categoria%20de%20frequ%26%23xEA%3Bncia%20CIOMS%20(Council%20for%20International%20Organizations%20of%20Medical%20Sciences)%20listada%20por%20ordem%20decrescente%20de%20gravidade%20m%26%23xE9%3Bdica%20dentro%20de%20cada%20categoria%20de%20frequ%26%23xEA%3Bncia%20e%20SOC.%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3ENas%20doses%20acima%20da%20varia%26%23xE7%3B%26%23xE3%3Bo%20de%20dose%20recomendada%2C%20eventos%20adversos%20foram%20semelhantes%20%26%23xE0%3Bqueles%20detalhados%20acima%2C%20mas%20foram%20relatados%20com%20mais%20frequ%26%23xEA%3Bncia.%3C%2Fp%3E%0A%3Cp%3EAp%26%23xF3%3Bs%20a%20an%26%23xE1%3Blise%20de%20estudos%20cl%26%23xED%3Bnicos%26%23xA0%3Bduplo-cegos%2C%26%23xA0%3Bplacebo-controlados%2C%26%23xA0%3Benvolvendo%20mais%20de%20700%26%23xA0%3Bpessoas-ano%26%23xA0%3Bs%26%23xF3%3B%20utilizando%20placebo%20e%20mais%20de%201300%20pessoas-ano%26%23xA0%3Btratadas%20com%20sildenafila%2C%20observou-%20se%20que%20n%26%23xE3%3Bo%20h%26%23xE1%3B%20diferen%26%23xE7%3Bas%20na%20taxa%20de%20incid%26%23xEA%3Bncia%20de%20infarto%20do%20mioc%26%23xE1%3Brdio%20ou%20a%20taxa%20de%20mortalidade%20cardiovascular%20em%20pacientes%20tratados%20com%20sildenafila%20comparados%20%26%23xE0%3Bqueles%20recebendo%20placebo.%20A%20taxa%20de%20incid%26%23xEA%3Bncia%20de%20infarto%20do%20mioc%26%23xE1%3Brdio%20foi%20de%20%2C1%20por%20100%26%23xA0%3Bpessoas-ano%2C%20para%20homens%20recebendo%20tanto%20placebo%20quanto%20sildenafila%2C%20e%20a%20taxa%20de%20incid%26%23xEA%3Bncia%20de%20mortalidade%20cardiovascular%20foi%20de%200%2C3%20por%20100%26%23xA0%3Bpessoas-ano%2C%26%23xA0%3Bpara%20homens%20recebendo%20tanto%20placebo%20quanto%20sildenafila.%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EEm%20casos%20de%20eventos%20adversos%2C%20notifique%20ao%20Sistema%20de%20Notifica%26%23xE7%3B%26%23xF5%3Bes%20em%20Vigil%26%23xE2%3Bncia%20Sanit%26%23xE1%3Bria%26%23x2013%3BNOTIVISA%2C%20dispon%26%23xED%3Bvel%20em%20www.anvisa.gov.br%2Fhotsite%20%2Fnotivisa%2Findex.htm%2C%20ou%20para%20a%20Vigil%26%23xE2%3Bncia%20Sanit%26%23xE1%3Bria%20Estadual%20ou%20Municipal.%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3ESUPERDOSE%3C%2Fstrong%3E%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3EEm%20estudos%20realizados%20com%20volunt%26%23xE1%3Brios%20sadios%20utilizando%20doses%20%26%23xFA%3Bnicas%20de%20at%26%23xE9%3B%20800mg%2C%20os%20eventos%20adversos%20foram%20semelhantes%20%26%23xE0%3Bqueles%20observados%20com%20doses%20inferiores%3B%20no%20entanto%2C%20a%20taxa%20de%20incid%26%23xEA%3Bncia%20e%20gravidade%20foram%20maiores.%20Em%20casos%20de%20superdosagem%2C%20medidas%20gerais%20de%20suporte%20devem%20ser%20adotadas%20conforme%20a%20necessidade.%3C%2Fp%3E%0A%3Cp%3EUma%20vez%20que%20a%20sildenafila%20se%20encontra%20fortemente%20ligada%20%26%23xE0%3Bs%20prote%26%23xED%3Bnas%20plasm%26%23xE1%3Bticas%20e%20n%26%23xE3%3Bo%20%26%23xE9%3B%20eliminada%20pela%20urina%2C%20n%26%23xE3%3Bo%20se%20espera%20que%20a%20di%26%23xE1%3Blise%20renal%20possa%20acelerar%20o%20clearance%20da%20sildenafila.%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EEm%20caso%20de%20intoxica%26%23xE7%3B%26%23xE3%3Bo%20ligue%20para%200800%20722%206001%2C%20se%20voc%26%23xEA%3B%20precisar%20de%20mais%20orienta%26%23xE7%3B%26%23xF5%3Bes.%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EDIZERES%20LEGAIS%3C%2Fstrong%3E%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3EM.S.%20no%26%23xA0%3B1.0370.%200561%3C%2Fp%3E%0A%3Cp%3EFarm.%20Resp.%3A%20Andreia%20Cavalcante%20Silva%3C%2Fp%3E%0A%3Cp%3ECRF-GO%26%23xA0%3Bno%26%23xA0%3B2.659%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3EFabricado%20por%3A%3C%2Fstrong%3E%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3ELABORAT%26%23xD3%3BRIOS%20PFIZER%20LTDA.%3C%2Fp%3E%0A%3Cp%3EGuarulhos-SP%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3ERegistrado%20por%3A%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3E%3Cstrong%3ELABORAT%26%23xD3%3BRIO%20TEUTO%3C%2Fstrong%3E%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3E%3Cstrong%3EBRASILEIRO%20S%2FA.%3C%2Fstrong%3E%3C%2Fp%3E%0A%3Cp%3ECNPJ%20%26%23x2013%3B%2017.159.229%2F0001%26%23xA0%3B-76%3C%2Fp%3E%0A%3Cp%3EVP%26%23xA0%3B7-D%26%23xA0%3BM%26%23xF3%3Bdulo%2011%20Qd.%2013%20%26%23x2013%3B%20DAIA%3C%2Fp%3E%0A%3Cp%3ECEP%26%23xA0%3B75132-140%26%23xA0%3B%26%23x2013%3B%20An%26%23xE1%3Bpolis%20%26%23x2013%3B%20GO%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Cp%3EInd%26%23xFA%3Bstria%20Brasileira%3C%2Fp%3E%0A%09%09%09%09%09%09
Ame
Não
ApresentarPrecoDePor
Sim
custom_label_0
campanha
MedicamentoControlado
Não
Cashback
Não
Antibiotico
Não
Generico
Não

Tributos e contexto fiscal

Preferência salva neste navegador; confirme o destino da operação.

NCM, CEST e tributos são referências fiscais brasileiras e podem não se aplicar em outros países.

Selecione a UF nesta seção para consultar a estimativa IBPT.

IBS/CBS: depende da operação, regime, data, destino e documento fiscal. Percentuais e CST/cClassTrib indisponíveis sem esse contexto.

VIAGRA 50MG CAIXA 8 COMP REV - Viagra

Dados estruturados

Veja todos os dados deste produto em JSON.

É exatamente o que a API devolve para este código de barras — pronto para o seu ERP, PIM ou PDV.

GET https://global.si5.com.br/api/produtos/7908236800162


            

Para chamar a API de verdade você usa um token pessoal — grátis até 100 consultas por dia.

Histórico de preços

Como o preço deste produto variou.

Preços de referência coletados em lojas online. Uma nova coleta acontece a cada cerca de 30 dias e sempre que o preço muda.

Último preçoR$ 289,81
Variação no período+15,5%
Menor / maiorR$ 250,99 / R$ 785,97
Coletas6
250,99 429,32 607,64 785,97 02/10/2026: R$ 250,99 (extrafarma.com.br) 11/10/2026: R$ 785,97 (araujo.vtexcommercestable.com.br) 12/10/2026: R$ 260,69 (ambiente.vtexcommercestable.com.br) 12/10/2026: R$ 260,69 (tamoio.vtexcommercestable.com.br) 15/10/2026: R$ 785,97 (drogariaricardoeletro.vtexcommercestable.com.br) 15/10/2026: R$ 289,81 (pill.com.br) 250,99 289,81 02/10 15/10
DataPreçoVariaçãoFonte
15/10/2026 R$ 289,81 primeira coleta pill.com.br
15/10/2026 R$ 785,97 primeira coleta drogariaricardoeletro.vtexcommercestable.com.br
12/10/2026 R$ 260,69 primeira coleta tamoio.vtexcommercestable.com.br
12/10/2026 R$ 260,69 primeira coleta ambiente.vtexcommercestable.com.br
11/10/2026 R$ 785,97 primeira coleta araujo.vtexcommercestable.com.br
02/10/2026 R$ 250,99 primeira coleta extrafarma.com.br

Valores informativos coletados de lojas online, sem garantia de que estejam atualizados. Não representam preço de venda do SI5 Global.